https://docs.google.com/document/d/1qG6eYM1LOBFRdUf4FwbmwnTgR49x9zC7oGTCgSbF9X4/edit?usp=drive_link

 

NICI Girls: A Parent’s Guide to the Hypermobile, Highly Sensitive, MCAS Phenotype 

A Systems-Biology Roadmap to Childhood Indicators, the Puberty “Crash,” Anabolic Reconstruction, and Beyond

 

NICI Girls: A Biological Roadmap for the Highly Sensitive Daughter

 

What if the behavioral challenges, severe fatigue, and sensory overwhelm your daughter is experiencing are not fixed psychiatric traits, but the symptoms of a dynamic, treatable biological system in distress? Medical science is currently undergoing a massive paradigm shift regarding how we view neurodevelopment. For example, clinical data now confirms that up to 30% of individuals with narcolepsy – a profound, physiological failure of sleep architecture – are initially misdiagnosed with ADHD simply because exhausted brains look hyperactive to a psychiatrist (Maski et al., 2021). Furthermore, extensive epidemiological research demonstrates that between 30% and 80% of individuals diagnosed with autism also meet the diagnostic criteria for ADHD (Surén et al., 2012). 

But the most profound revelation lies in the body’s physical hardware: approximately 31% of autistic individuals exhibit clinical joint hypermobility, while 39% of individuals diagnosed with EDS/HSD meet the diagnostic criteria for autism (Baeza-Velasco et al., 2018). The Neuro-Immuno-Connective Instability (NICI) framework postulates that for this specific phenotype, a neurodivergent diagnosis is not a fixed, inescapable end-state. However, this dynamic biology comes with a critical warning. If a highly sensitive girl’s underlying joint laxity and Mast Cell Activation Syndrome (MCAS) are left untreated, her immune system remains in a state of chronic panic. Over time, this unmanaged inflammation actively degrades the brain’s sensory filters, progressively worsening and amplifying “autistic” symptoms like extreme sensory sensitivity, severe autonomic anxiety, and eventual developmental burnout. For parents of sensitive daughters, this manual is a preventative roadmap to intercept that exact physiological crash before it happens. For parents whose daughters already hold an autism diagnosis, it offers profound, actionable hope: by treating the root-cause instability of her connective tissue and mast cells, you can structurally calm her nervous system from the inside out and significantly decrease the severity of her daily symptoms. 

To understand how this dynamic biology manifests, we can look to a groundbreaking 2025 study from the SPARK cohort, which finally moved away from treating autism as a single monolith (Litman et al., 2025). By using a “person-centered” computational model on over 5,000 children, researchers identified four distinct biological and clinical subtypes. Strikingly, the Neuro-Immuno-Connective Instability (NICI) framework maps directly onto two of these specific subgroups, providing a biological explanation for up to 47% of the children in the cohort:

• The “Social and Behavioral Challenges” Subgroup (37% of the Cohort): This group represents the absolute core of the NICI “AuDHD / Pubertal Crash” phenotype. These children exhibit autistic traits but generally hit early motor milestones on time – likely because a young child’s light body weight does not yet overwhelm their lax connective tissue. Their defining feature is a massive overlap with ADHD, anxiety, depression, and OCD. Under the NICI framework, this ADHD is often the direct result of a sleep architecture collapse driven by undiagnosed Upper Airway Resistance Syndrome (UARS) and the resulting adrenaline micro-arousals (Guilleminault et al., 1993). Furthermore, their anxiety and OCD are not purely psychiatric; they are symptoms of “Proprioceptive Panic” and dysautonomia (Eccles et al., 2015). Their brains are constantly flooded with adrenaline to stabilize loose joints, leaving their amygdalas structurally hyper-reactive to the chronic mechanical threat of gravity (Eccles et al., 2012).This mechanical and autonomic strain has severe, measurable psychiatric consequences. Longitudinal cohort data definitively proves that the presence of generalized joint hypermobility at age 14 is a significant predictor for the development of clinical depression and anxiety by age 18 (Eccles et al., 2022). Crucially, this psychiatric risk is directly mediated by an elevated resting heart rate – a clear marker of dysautonomia and physiological hyperarousal – proving that their mood disorders are fundamentally rooted in their biological hardware (Eccles et al., 2022). The staggering intersection of these conditions is increasingly undeniable. Generalized joint laxity is drastically overrepresented in individuals seeking mental health or neurodevelopmental services (present in 38% of patients compared to 19% of controls), carrying a profound burden of orthostatic intolerance and gastrointestinal symptoms. Crucially, statistical mediation analysis confirms that this underlying dysautonomia formally drives and mediates the link between joint hypermobility and clinical anxiety (Csecs et al., 2021).
• The “Broadly Affected” Subgroup (10% of the Cohort): This group represents the severe, early-onset end of the NICI spectrum where the immune system’s catabolic destruction of tissue is hyperactive from birth. These children experience early developmental delays, which the NICI model explains as severe dyspraxia; their lax joints prevent the brain from locating the body in space, leading to delayed walking and biomechanical compensations like W-sitting or toe-walking (Ha & Sung, 2022; Engelbert et al., 2011). Their profound communication difficulties align perfectly with the Rauch Effect: a state where chronic neuro-inflammation and autonomic panic physically starve the brain’s speech center (Broca’s area) of blood flow, driving frequent or permanent mutism (Rauch et al., 1996). Finally, the NICI theory reframes their intense repetitive behaviors (stimming) not as a behavioral tic, but as “Fascial Tensegrity Auto-Regulation” – a mechanical coping strategy where the child moves rapidly to generate a piezoelectric electrical charge that temporarily stiffens their connective tissue and maps their body in space (Fukada & Yasuda, 1964; Ingber, 2008).

Currently, the allopathic medical system’s tendency is to silo the body – sending the brain to psychiatry, the joints to rheumatology, and the allergies to immunology. This fails to capture the multifaceted, dynamic reality of your child.

The NICI framework validates what you already know: your daughter is not a collection of independent disorders. She is a unified, highly sensitive biological ecosystem. When her structural foundation (connective tissue) is lax, her security system (mast cells) panics, and her biological wiring (the brain’s Perineuronal Nets) becomes overwhelmed by the resulting neuro-inflammatory noise.

For a female child with this phenotype, puberty is not merely a reproductive milestone; it is a massive inflammatory and mechanical event. This guide translates the NICI model’s deep biology into an actionable playbook. It is designed to help you look past the behavioral labels, spot early hardware failures, secure the right testing, and intercept the pubertal hormone crash so you can stabilize her biology from the ground up.

Part 1: The Early Warning System (Identifying the Phenotype)

Long before the hormonal surge of puberty, the NICI phenotype leaves a trail of structural and immunological breadcrumbs. By looking past behavioral labels and observing biomechanics, you can identify the phenotype early.

1. Craniofacial & Dental Indicators

• The “Dentist’s Nightmare” (Lidocaine Resistance): Does she cry in pain during dental work despite being numbed?. Connective tissue laxity allows local anesthetics to diffuse away from the nerve too rapidly. This mechanical failure of local anesthesia is a well-documented phenomenon in hypermobility spectrum disorders (Hakim et al., 2017). Action: Request Marcaine/Bupivacaine or alternative nerve blocks.
• High, Narrow Palate: A highly arched roof of the mouth and crowded teeth indicate low orofacial muscle tone during development. This is a massive red flag for pediatric airway collapse and mouth-breathing, which alters craniofacial development and predisposes children to Obstructive Sleep Apnea (OSA) and Upper Airway Resistance Syndrome (UARS) (Guilleminault et al., 2004).

2. Biomechanical & Motor Indicators

• W-Sitting & Toe-Walking: Sitting in a ‘W’ shape on the floor provides a dramatically widened base of support for a child with core hypotonia (low muscle tone), acting as a physical compensation for delayed postural control (Ha & Sung, 2022). Toe-walking is often a biomechanical hack, not just a sensory quirk; by locking her calf muscles, she artificially creates tension to stabilize “floppy,” hypermobile ankles, dynamically compensating for the difficulty of stabilizing her center of mass over a small base of support (Soangra et al., 2021; Engelbert et al., 2011).
• The Metabolic Cost of Movement & “Growing Pains”: True physiological “growing pains” are a biological misnomer. In the NICI phenotype, chronic nighttime leg and joint pain is the physical manifestation of mechanical strain and micro-tearing in fragile connective tissue resulting from daily movement. Clinical biomechanics confirm that individuals with hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders have significantly lower Achilles tendon stiffness and increased tendon compliance. This floppy “hardware” forces the body to redistribute mechanical work to the proximal joints, such as the hips and knees, which actively and significantly increases the metabolic energy cost of walking. When a NICI girl complains of profound exhaustion after a simple walk, she is not simply out of shape; her fatigue is mechanical and metabolic, driven by a measurable energy drain caused by her connective tissue (Sheehan et al., 2026).
• The “Clumsy Bruiser”: Constantly bumping into doorframes is a failure of proprioception (the brain’s GPS cannot locate loose joints in space), a heavily documented neurological deficit in Ehlers-Danlos patients whose mechanoreceptors fail to provide accurate feedback in lax tissue (Clayton et al., 2015). This is often combined with Binocular Vision Dysfunction (lax eye muscles failing to maintain depth perception). Easy bruising is a hallmark trait of hEDS, and if it occurs heavily in the legs alongside disproportionate fat distribution, look into Lipedema. The U.S. Standard of Care consensus guidelines now formally recognize hypermobile joints and connective tissue laxity as highly prevalent structural comorbidities of Lipedema (Herbst et al., 2021).

3. Immune & Autonomic Indicators

• “Picky Eating” as Functional Avoidance (ARFID): Food refusal is rarely behavioral control. Lax gut tissue causes delayed gastric emptying (gastroparesis), and mast cells in the gut react to foods. Eating causes visceral pain, bloating, or histamine flushing, driving restrictive food intake disorders (ARFID) which are highly comorbid with hypermobility (Zheng et al., 2023).
• The “Shower Sit” & Temperature Dysregulation: Frequently sitting down in the shower, going from freezing to overheating, having legs turn mottled purple (acrocyanosis) or going numb when standing, or feeling lightheaded or having vision get spotty from going from crouching or sitting to standing. This is early dysautonomia/POTS; her autonomic nerves are struggling to constrict her lax blood vessels against gravity. In the hypermobile phenotype, the connective tissue forming the blood vessels is highly distensible, and the unmyelinated C-fibers responsible for signaling these vessels to constrict are often damaged or destroyed. This physical failure of vasoconstriction causes gravity to pull blood into the lower extremities – creating the visible pooling known as acrocyanosis – and directly results in cerebral hypoperfusion (a lack of blood and oxygen to the brain) (Haensch et al., 2014). It is this transient loss of cerebral blood flow upon standing that immediately triggers the visual micro-stuttering, dizziness, and pre-syncope (Kavi et al., 2016).
• Dermatographia (“Skin Writing”): Lightly scratching her skin leaves a raised, red, itchy welt minutes later. Her mast cells are hyper-reactive to mechanical stress and stretching, not just classic immune allergens. This is driven by a “mechano-immunologic” trigger, wherein physical friction, pressure, and shear forces lower the threshold for degranulation, causing hyper-sensitive mast cells located along the exact path of the scratch to rapidly release histamine and other neurogenic inflammatory mediators (Kolkhir et al., 2019). 

Part 2: High-Impact Priority: Navigating the Puberty “Crash”

Because NICI girls face uniquely severe biological shifts during adolescence, understanding and preempting the pubertal crash is one of the highest-impact interventions you can make. The epidemiological and genetic reality of this crash is undeniable. Recent genomic analyses confirm that “late-diagnosed” autism – which frequently occurs during adolescence for females – is not simply a delayed realization, but a genetically distinct trajectory with a unique polygenic architecture (Zhang et al., 2025). This distinct genetic profile is strongly associated with the late-childhood emergence of socioemotional difficulties and has moderate-to-high genetic correlations with co-occurring mental health conditions and ADHD (Zhang et al., 2025). Tragically, because this pubertal crash does not look like early-childhood autism, these girls are routinely subjected to diagnostic overshadowing and systemically invalidated by the medical establishment (medically gaslit). Clinical data reveals that 31.7% of autistic women report being misdiagnosed with personality disorders (like Borderline Personality Disorder), anxiety, or mood disorders prior to their autism diagnosis (Kentrou et al., 2024). The introduction of cycling sex hormones acts as a biological stress test on this unique genetic trajectory, pushing her fragile extracellular matrix and hyper-reactive immune system to the breaking point. Qualitative research highlights a devastating ‘Psychiatric Misdiagnosis Pipeline’ where autistic adults, particularly women, are heavily misdiagnosed with Borderline Personality Disorder (BPD/EUPD) because systemic practitioners mistake autistic shutdowns for dissociation, and misinterpret trauma or self-harm without acknowledging the underlying neurodivergence. For these women, finally receiving an affirmative autism diagnosis is universally described as ‘life-changing,’ successfully shifting the clinical focus away from harmful behavioral ‘correction’ and toward crucial neurotype acceptance (Tamilson et al., 2025). 

1. The Estrogen/Progesterone Double Hit & Endometriosis

• The Estrogen-Histamine Fire (Chemical Demolition): Mast cells (part of the immune system) have estrogen receptors. When estrogen spikes, it directly triggers mast cells to degranulate, releasing histamine and Matrix Metalloproteinases (specifically MMP-9, an enzyme that degrades connective tissue and brain myelin). Academic literature confirms that estrogen establishes a self-reinforcing inflammatory loop by directly binding to mast cells, triggering degranulation and amplifying pain signaling pathways (Zhu et al., 2024). Furthermore, estrogen actively downregulates Diamine Oxidase (DAO), the primary enzyme responsible for clearing histamine in the gut (Maintz & Novak, 2007).
• Endometriosis as a Mast Cell Disease: This systemic fire frequently manifests as Endometriosis, a condition that shares a profound clinical overlap with the NICI phenotype. Clinical prevalence studies demonstrate that Endometriosis is highly comorbid with connective tissue disorders; while it affects roughly 5% to 10% of the general female population, it is reported in up to 25% of individuals with hypermobile Ehlers-Danlos Syndrome (hEDS) (Castori et al., 2012). Furthermore, clinical research confirms that endometriotic lesions are heavily infiltrated by degranulating mast cells (Borelli et al., 2020). This means the pelvic tissue itself directly participates in the vicious Estrogen-Histamine vortex, physically paralyzing the pelvic floor and massively amplifying the central nervous system’s pain loop.
• The Progesterone Loosening (Mechanical Failure): In the luteal phase (the week before her period), progesterone and relaxin spike. Progesterone biologically alters collagen metabolism, and surges in these female hormones are clinically documented to decrease musculotendinous stiffness and actively increase joint/ligament laxity to prepare the female body for potential pregnancy (Park et al., 2009; Castillo et al., 2011).
• The Result: Right before her period, her joints lose stability (causing pain and clumsiness). This laxity triggers a mechanical stress alarm, because mast cells are highly mechanosensitive and directly degranulate in response to abnormal physical stretch, shear forces, and mechanical stress (Navarro et al., 2014). Simultaneously, her estrogen surge triggers a chemical stress alarm by binding directly to mast cell estrogen receptors, initiating a self-reinforcing inflammatory cascade (Zhu et al., 2024). The resulting massive release of mast cell-derived Matrix Metalloproteinase-9 (MMP-9) crosses the blood-brain barrier and chemically “melts” or degrades her brain’s Perineuronal Nets (PNNs) – the essential structural extracellular matrix that encases parvalbumin (PV+) interneurons, enabling the GABA system of her sensory brakes to function (Gray et al., 2008). This acute neuro-inflammatory lysis and loss of central nervous system inhibition leads to what can clinically present as severe Premenstrual Dysphoric Disorder (PMDD), Bipolar mood swings, autistic burnout, or mutism. The epidemiological overlap here is undeniable; seminal observer-rated clinical research demonstrates that up to 92% of autistic women fulfill the diagnostic criteria for PMDD, compared to just 11% of neurotypical controls (Obaydi & Puri, 2008). 

2. The Pubertal Growth Spurt: The Dyspraxic Motor Crash

• The Mechanism: A hypermobile brain relies heavily on stretching its fascia and ligaments to figure out where its limbs are in space (proprioception). Because the lax connective tissue in the NICI phenotype provides blunted and inaccurate mechanoreceptor feedback, the brain must continuously seek extreme tension and end-range stretch to “find” the body’s physical boundaries in space (Smith et al., 2013). During puberty, long bones grow rapidly while surging levels of estrogen and relaxin biologically alter collagen metabolism, making her ligaments exceptionally loose. Clinical endocrinology confirms that relaxin and estrogen act synergistically during female hormonal shifts to decrease musculotendinous stiffness and actively upregulate joint laxity, severely compromising structural stability just as the adolescent body’s mechanical load increases (Dehghan et al., 2014).
• The Result: Because the bones are suddenly longer but the “rubber bands” holding them together have lost their tension, her brain loses its internal body map. The proprioceptive signals sent from her lax joints to the central nervous system become fragmented and degraded. She isn’t just “clumsy”; she is experiencing a terrifying neurological disconnect, driving severe physical anxiety, dyspraxia, and the sudden inability to perform motor tasks she used to do easily. Clinical research heavily confirms this exact neuro-mechanical collapse; the profound overlap between joint hypermobility, severe proprioceptive anxiety, and Developmental Coordination Disorder (dyspraxia) is fundamentally driven by the brain’s autonomic panic response when it can no longer reliably locate the body in physical space (Kirby & Davies, 2007; Eccles et al., 2015). Recent data-informed conceptual models prove that variant connective tissue (manifest as joint hypermobility) acts as the biological moderator determining whether this proprioceptive sensory imprecision – or ‘proprioceptive surprise’ – translates into severe emotional dysregulation in neurodivergent populations (Eccles et al., 2024). 

3. The Menstrual Toll: The Iron-Dopamine Collapse

• The Mechanism: The estrogen-histamine loop often causes extremely heavy, painful periods (menorrhagia), leading to massive blood loss. Because mast cells release histamine – a potent vasodilator that drastically increases vascular permeability – their degranulation in the uterine tissue actively exacerbates heavy bleeding and dysmenorrhea. Furthermore, because of MCAS and gut dysmotility, her body physically cannot absorb enough dietary iron to replace what is lost. This is not simply a dietary failure, but an active inflammatory blockade: when mast cells degranulate systemically, they release inflammatory cytokines (specifically IL-6) that signal the liver to massively overproduce a hormone called hepcidin (Nemeth et al., 2003). Hepcidin then travels to the gut and physically degrades ferroportin – the cellular “doorway” or channel that allows dietary iron to enter the bloodstream – effectively locking iron out of the body (Ganz, 2003).

• The Result: Iron (Ferritin) is a non-negotiable cofactor for Tyrosine Hydroxylase, the rate-limiting enzyme required to synthesize Dopamine (Daubner et al., 2011). When her ferritin drops, the brain physically cannot produce dopamine. This iron deficiency directly causes a catastrophic worsening of her ADHD and executive function symptoms (Felt et al., 2006), and profoundly destabilizes her orexin/sleep architecture, frequently manifesting as severe sleep fragmentation and Restless Legs Syndrome (Earley et al., 2014).

4. The Hidden Bone Density Threat (Heparin & Mast Cells)

• The Mechanism: Puberty is the critical window where a human female builds her peak bone mass for the rest of her life. During this narrow developmental period, females accrue nearly 40% of their total adult skeletal mass (Baxter-Jones et al., 2011). When mast cells degranulate, they do not just release histamine; they release massive amounts of Heparin (a blood thinner). This heparin is co-stored in their secretory granules and dumped into the surrounding tissue and systemic circulation during an inflammatory cascade, compounding the breakdown of the structural matrix (Kalesnikoff & Galli, 2008).
• The Result: Chronic, systemic heparin release actively drives bone resorption (breakdown). Mast cell-derived heparin has been shown to strongly upregulate osteoclast activity, effectively prompting the body to reabsorb and dissolve its own bone matrix (Guillaume et al., 2013; Fuller et al., 1991). Furthermore, skeletal mechanics dictate that vertical mechanical loading and weight-bearing impact are the primary physiological stimuli required to generate and maintain bone mineral density (Cleveland Clinic, 2024). Because NICI girls frequently avoid weight-bearing exercise and impact activities due to severe joint pain, proprioceptive failure, and the constant threat of joint subluxation or dislocation (Medical News Today, 2024), their skeleton is deprived of the physical tension needed to build mass. This devastating combination – active chemical degradation by heparin paired with the mechanical disuse driven by hypermobility – puts them at an extreme, compounding risk for early-onset osteopenia. 

5. Social Camouflaging, Mitochondrial Allostatic Load, and Autistic Burnout

• The Mechanism (Toxic Stress & The HPA Axis): For a NICI girl, attempting to mask her neurodivergent traits and compensate for her failing physical hardware in a neurotypical environment requires immense biological resources. Social camouflaging is not a psychological choice or a mere behavioral adaptation; it represents a profound mismatch between external demands and internal capacity, acting as a “toxic stressor” and a severe form of Chronic Adolescent Stress (CAS). This relentless toxic stress overloads the Hypothalamic-Pituitary-Adrenal (HPA) axis, bathing the nervous system in chronic glucocorticoids. This initiates a destructive physiological cascade known as Mitochondrial Allostatic Load (MAL), which actively impairs ATP synthesis, increases oxidative stress, and alters mitochondrial dynamics across the nervous system (Mahony & O’Ryan, 2022).
• The Result (The Neuro-Metabolic Crisis): Autistic burnout is not merely a psychological phenomenon; it is a measurable neuro-metabolic crisis. Under the burden of Mitochondrial Allostatic Load, the brain undergoes severe metabolic reprogramming. This energy deficit forces microglia (the brain’s immune cells) to shift away from healthy oxidative phosphorylation and into an aggressive, pro-inflammatory glycolytic state, triggering widespread neuroinflammation and glutamatergic excitotoxicity. This active destruction of mitochondrial energy production and the simultaneous neuroimmune panic directly drive the profound fatigue, loss of skills, and increased suicidality defining autistic burnout, fundamentally linking the condition to severe co-morbid psychopathology (Mahony & O’Ryan, 2022).

The Interventions (The Luteal Phase Blockade & Beyond)

• The Pre-Menstrual Shield: 5 to 7 days before her cycle begins (before mood swings spike), implement daily H1 and H2 antihistamines (e.g., Cetirizine + Famotidine) and natural flavonoids, if tolerated (e.g., liposomal Luteolin + Quercetin). Current immunological consensus dictates that combining H1 and H2 antihistamines provides a critical dual-receptor blockade, preventing systemic histamine binding across multiple tissue types far more effectively than using either medication in isolation (Afrin et al., 2016). Furthermore, this protocol places a “chemical lid” on mast cells, blocking MMP-9 release before the estrogen surge triggers mast cell activation. Recent pharmacological research supports this mechanism, demonstrating that natural flavonoids like luteolin act as potent mast cell stabilizers that actively and significantly inhibit the release of Matrix Metalloproteinase-9 (MMP-9), performing even more effectively than prescription stabilizers like cromolyn sodium (Tsilioni & Theoharides, 2024). Emerging neuroimmunological research further highlights that these specific flavonoids – luteolin and quercetin – do not just stabilize peripheral immunity; they act as potent neuroprotectants that inhibit the release of histamine, IL-6, and TNF-α, directly suppressing the microglial activation and neuroinflammation that drives cognitive dysfunction and “brain fog” in the central nervous system (Kovacheva et al., 2024).
• DAO Enzyme Support: Supplement with Diamine Oxidase (DAO) enzymes 15 minutes before meals during the luteal phase to clear dietary histamine, lowering the overall inflammatory bucket. This is biologically critical during the premenstrual window because estrogen actively downregulates the body’s natural production of DAO – the primary enzyme responsible for degrading extracellular histamine in the gut (Maintz & Novak, 2007). By providing exogenous DAO, you artificially restore this enzymatic clearance pathway, preventing dietary histamine from overflowing into systemic circulation and amplifying the estrogen-histamine inflammatory loop.
• Oral Cromolyn Sodium: If Mast Cell Activation Syndrome (MCAS) symptoms are severe, consider oral cromolyn sodium 15-20 minutes before meals. Because oral cromolyn is minimally absorbed into the systemic bloodstream (less than 1%), it acts locally within the gastrointestinal tract (Healio, 2025). It functionally coats the enteric mast cells, stabilizing their cell membranes by inhibiting calcium influx, which effectively raises the cellular threshold against both mechanical stretch and chemical degranulation. This localized membrane stabilization prevents the massive release of preformed inflammatory mediators – such as histamine and leukotrienes – directly into the gut lining, ensuring the inflammatory cascade is chemically blocked before dietary triggers or gastric stretching can initiate it (StatPearls, 2024; Afrin et al., 2016).
• Isometric “Casting” & Bone Building: Advise against heavy stretching, yoga, or high-impact sports during the luteal phase when ligaments are at their weakest. Clinical endocrinology confirms that surges in relaxin and progesterone actively decrease musculotendinous stiffness during this premenstrual window, leaving hypermobile joints highly vulnerable to subluxation and injury (Park et al., 2009). Emphasize isometric strength training (contracting muscles without moving the joint) to build a “muscular cast” and safely provide the mechanical loading required to build bone density against the heparin threat. Isometric loading provides the necessary mechanical strain to the bone through muscle tension, stimulating osteogenesis (bone building) without introducing chaotic shear forces or dangerous end-range stretching to already compromised ligaments (Simmonds & Keer, 2007). Consider supplementing with Creatine if tolerated. Clinical reviews confirm that creatine acts as a critical energy reserve in the brain and muscles, bypassing impaired mitochondrial pathways to rapidly resynthesize ATP and sustain cellular bioenergetics during muscular exertion (Kreider et al., 2022).
• Electrolyte Loading: Increase sodium and fluids the week prior to combat the blood-pooling (POTS) and dizziness caused by progesterone-loosened blood vessels. During the luteal phase, the surge in female sex hormones – specifically progesterone – actively promotes vasodilation and decreases venous tone, severely compromising the autonomic nervous system’s ability to constrict blood vessels against gravity. To counteract this hormone-driven orthostatic intolerance, aggressive electrolyte loading (often 3 to 10 grams of sodium daily) combined with high fluid intake is clinically required. Cardiovascular research demonstrates that a high-sodium diet physically expands plasma volume, improves venous return to the heart, and significantly reduces both the compensatory standing heart rate and the elevated norepinephrine levels that drive POTS symptoms (Garland et al., 2021).
• Iron Repletion & “Walking Anemia”: Aggressively monitor Ferritin levels (aiming for a minimum of >50 ng/mL) and do not rely on Hemoglobin alone. Standard medical practice often relies on Hemoglobin (the protein in red blood cells that transports oxygen) to diagnose iron deficiency; however, hemoglobin is a late-stage functional marker. Ferritin, on the other hand, represents the body’s deep tissue iron storage. A patient can have entirely normal hemoglobin but severely depleted ferritin, a state known clinically as Non-Anemic Iron Deficiency (NAID), or “walking anemia” (Soppi, 2018). While standard lab reference ranges often flag ferritin as “normal” down to 10-15 ng/mL, clinical hematology confirms that levels below 50 ng/mL represent a profound functional deficiency. At this level, the brain is actively starved of the iron needed to synthesize dopamine, directly triggering restless legs syndrome, profound fatigue, and cognitive dysfunction long before frank anemia sets in (Earley et al., 2014).
• The Diagnostic Gap: Furthermore, routine blood tests cannot actually measure the iron physically stored deep inside the organs or the brain. The only definitive way to measure true organ iron storage is via a highly invasive bone marrow biopsy (the clinical “gold standard” where marrow is extracted and stained for iron) or specialized T2* MRIs for the liver and heart. Because these procedures are highly invasive and impractical for routine care, we must treat falling ferritin aggressively rather than waiting for the hemoglobin to crash.
• The Mechanism (The Hepcidin Blockade): When mast cells degranulate, they release inflammatory cytokines (specifically IL-6) that signal the liver to massively overproduce a hormone called hepcidin. Hepcidin then travels to the gut and physically degrades ferroportin – the cellular “doorway” or opening that allows dietary iron to enter the bloodstream – effectively locking iron out of the body (Ganz, 2003). Because this inflammatory response physically closes the pathway for gut absorption, you must utilize IV iron infusions if oral iron absorption is blocked by this hepcidin-driven inflammation.
• Low-Dose Naltrexone (LDN) for Pain and Inflammation: For chronic pain phenotypes like fibromyalgia – frequently co-occurring with NICI – Low-Dose Naltrexone (LDN) operates as a promising neuro-immune modulator. While large-scale trials are pending, current clinical evidence indicates that LDN can reduce pain and improve quality of life, alongside documented reductions in plasma concentrations of inflammatory cytokines, with baseline erythrocyte sedimentation rate (ESR) serving as a potential predictor of therapeutic response (Partridge et al., 2023). 

Part 3: The Core Biological “Hardware” Bugs (Genetics, Immunity, & Neuropathy)

To understand exactly why the interventions above are necessary, we must examine the specific cellular breakdowns driving the NICI phenotype. The tissue in a NICI body is not merely built suboptimally from conception due to genetic factors; it is being actively and progressively digested from the inside out.

1. The Genetic Drivers of Instability

Breakthrough Genome-Wide Association Study (GWAS) meta-analyses have moved beyond structural collagen genes to pinpoint the exact regulatory and metabolic drivers:

• ACKR3 (The Environmental Sensor): A genome-wide significant risk locus has been identified in the ACKR3 gene (Petrucci-Nelson et al., 2025). This variant generates a de novo binding site for the Aryl Hydrocarbon Receptor (AHR), the body’s primary sensor for environmental toxins, microplastics, and dietary metabolites. This effectively wires the patient’s immune regulation directly to their environment, providing the molecular proof for their extreme chemical sensitivities.
• SLC39A13 (The Zinc Paradox): This gene encodes the ZIP13 zinc transporter, a critical transmembrane protein that regulates intracellular zinc distribution (Bin et al., 2014). Dysfunction or mutation of this gene results in a devastating structural “Double Hit.” First, the body lacks the compartmentalized intracellular zinc required in the early secretory pathway for proper collagen folding and cross-linking. This mechanical failure directly results in fragile joints, weakened connective tissue, and a highly specific hypermobile phenotype clinically recognized as Spondylodysplastic Ehlers-Danlos Syndrome (spEDS) (Fukada et al., 2008). Second, this failure of cellular zinc regulation aberrantly supercharges Matrix Metalloproteinases (MMPs). MMPs are inherently zinc-dependent enzymes; when local zinc homeostasis is disrupted and extracellular zinc pools mislocate, these enzymes become hyperactivated and actively degrade the extracellular matrix, dissolving surrounding tissue (Ding et al., 2024).
• MTHFR (Folate-Dependent Hypermobility Syndrome): Polymorphisms in the MTHFR gene create a severe methylation bottleneck that directly degrades connective tissue. Decreased MTHFR activity leads to a loss of epigenetic control, which specifically derepresses Matrix Metalloproteinase-2 (MMP-2) (Courseault et al., 2023). This unchecked MMP-2 enzyme actively cleaves decorin – the vital glycoprotein that glues collagen fibrils together – leading to disorganized extracellular matrix, extreme tissue fragility, and increased fibrosis (Courseault et al., 2023).
• HLA-B & MT-CYB (The Immune & Infection Drivers): To explain the constant infections and MCAS hyper-reactivity seen in this phenotype, whole-genome sequencing of hypermobile EDS patients has identified highly specific genetic variants in the HLA-B and MT-CYB genes (Shirvani et al., 2024). The HLA-B variant (p.Leu119Trp) disrupts antigen presentation and immune modulation, while MT-CYB variants compromise the mitochondrial energy production essential for proper mast cell regulation, driving the population’s well-documented mast cell hypersensitivity and recurrent infection risk (Shirvani et al., 2024).
• KLK15 (The Assembly Failure): Pathogenic variants in KLK15 disrupt the compartmentalization of Lysyl Oxidase (LOX), leading to disorganized collagen fibrils and tissue laxity, further compounding the structural failure (Gensemer et al., 2025).

2. Cellular “Hardware” Bugs: The Ion Pump and Mitochondrial Crash

The genetic mutations establishing this fragile connective tissue baseline create a cascading breakdown of the body’s cellular “hardware.” This microscopic failure dictates the crushing fatigue and exertion intolerance the patient experiences daily.

• The $\beta_{2}$-Adrenergic and $Na^{+}/K^{+}$-ATPase Failure: Chronic sympathetic overactivity combined with vascular dysregulation causes severe dysfunction of the $\beta_{2}$-adrenergic receptors. Normally, the $\beta_{2}$-adrenergic receptor is responsible for stimulating the $Na^{+}/K^{+}$-ATPase pump in skeletal muscles to maintain cellular homeostasis. When this receptor is dysfunctional, the $Na^{+}/K^{+}$-ATPase pump is insufficiently stimulated, failing to clear sodium and causing a massive intracellular sodium overload (Wirth & Scheibenbogen, 2021).
• The Calcium Influx and Mitochondrial Collapse: This severe sodium overload forces the cellular sodium-calcium exchanger (NCX) to reverse its transport direction. Instead of exporting calcium, the cell begins importing it, leading to a toxic intracellular calcium overload. This calcium overload wreaks havoc on the mitochondria, cytoplasmic metabolism, and the endothelium, creating a vicious cycle of energetic failure that clinically manifests as post-exertional malaise (PEM) and profound exercise intolerance (Wirth & Scheibenbogen, 2021).
• Endoplasmic Reticulum Stress and WASF3: Compounding this mitochondrial collapse is the role of the Wiskott-Aldrich Syndrome Protein Family Member 3 (WASF3). Viral infections and cellular damage trigger Endoplasmic Reticulum (ER) stress, which induces the overexpression of WASF3. This excess WASF3 physically disrupts mitochondrial respiratory supercomplexes and inhibits oxidative phosphorylation, directly suppressing the body’s ability to produce ATP and cementing the state of chronic exhaustion (Syed et al., 2025).
• Mitochondrial-ECM Crosstalk: Why does an energy deficit lead to hypermobility? The answer lies in the cellular powerhouses. Mitochondrial dysfunction – specifically impaired oxidative phosphorylation (OXPHOS) and elevated reactive oxygen species (ROS) – actively disrupts Extracellular Matrix (ECM) homeostasis (Shirvani et al., 2025). Building and maintaining strong collagen requires massive amounts of cellular ATP (Shirvani et al., 2025). Therefore, the failure to build resilient connective tissue in the NICI phenotype is directly tied to a foundational mitochondrial energy deficit, locking her in a cycle of tissue fragility and exhaustion.
• The Intervention Strategy: To intercept this crash, we have to support the mitochondria directly. Targeted therapeutic interventions demonstrate that Coenzyme Q10 (CoQ10) supplementation directly targets this post-viral mitochondrial dysfunction to restore electron flow in the respiratory chain, enhance ATP generation, and reduce fatigue [Mantle et al., 2024]. By addressing the metabolic deficit directly, we can begin to rebuild her biological resilience.

3. Complement Exhaustion & The Stealth Pathogen

Parents frequently report that their child is simultaneously plagued by hyper-allergic reactions and frequent, severe infections that cause significant regression or an increase in autistic traits.

• The Mechanism (Complement Exhaustion): A recent, highly targeted proteomic analysis of serum in hypermobile Ehlers-Danlos Syndrome (hEDS) patients identified a distinct immunologic signature of “Complement Exhaustion.” The study revealed a significant, widespread depletion of key Complement System proteins – specifically C1QA, C3, C8A, C8B, and C9 – compared to matched controls (Griggs et al., 2025). This depletion is the direct result of the structural reality of the disease: the constant mechanical micro-tearing of fragile connective tissue throughout the body continuously releases intracellular proteins into the extracellular space. The immune system recognizes these spilled cellular contents as Damage-Associated Molecular Patterns (DAMPs), which act as acute danger signals that aggressively trigger the complement cascade to clear the tissue debris and initiate local inflammation (Neher et al., 2011). Because hypermobile joints lack structural stability and are constantly subjected to mechanical trauma during daily movement, the innate immune system is forced to work overtime. It perpetually triggers the complement cascade in response to the physical damage until the systemic supply of these critical circulating proteins is functionally exhausted.
• The Vulnerability (Immunodeficiency & Stealth Pathogens): Because the hypermobile body’s constant mechanical micro-tearing exhausts its circulating supply of complement proteins, the patient is left in a state of localized functional immunodeficiency. This immunological blind spot provides the perfect physiological opportunity for stealth pathogens, such as Borrelia burgdorferi (the causative agent of Lyme disease), to opportunistically entrench themselves in the connective tissue. Evolutionary microbiology confirms that B. burgdorferi dedicates a massive portion of its genome specifically to evading the host’s complement system; it produces outer surface proteins (specifically CspA) that actively bind to human complement regulators, directly inhibiting the terminal complement pathway and blocking the assembly of the membrane attack complex (Hallström et al., 2013). When this stealth pathogen successfully embeds in the tissue completely unchecked by the exhausted complement system, the immune system defaults to its primitive frontline defenders: mast cells. Clinical research confirms that Borrelia spirochetes directly induce localized mast cell activation and aggressive cytokine release (Talkington & Nickell, 1999). This traps the body in a futile inflammatory loop – mast cells endlessly degranulate to fight an entrenched pathogen they structurally cannot clear, driving profound neuroinflammation, severe chronic fatigue, and a relentless cycle of maladaptive mast cell panic. 

4. Peripheral Neuro-Immune Degeneration

Dysautonomia (like POTS) is not just caused by stretchy blood vessels pooling blood; it is driven by the physical destruction of the autonomic nervous system’s wiring.

• The Excitotoxic Burnout: Mast cells physically align alongside small unmyelinated C-fibers (nociceptors). Mechanical strain from lax joints causes these nerves to release Substance P and CGRP, triggering massive, non-allergic mast cell degranulation via the MRGPRX2 receptor (Theoharides et al., 2019).
• The Structural Failure: When mast cells degranulate, they bathe the nerves in a toxic, inflammatory soup (glutamate, TNF, IL-1β). This intense stimulation stimulates the nerves to death (excitotoxicity). The body functionally “burns out” and retracts these small nerve fibers to protect itself (Small Fiber Neuropathy). Because these are the exact fibers (unmyelinated C-fibers) responsible for releasing norepinephrine to signal blood vessels to constrict against gravity, their physical destruction directly causes the lack of vasoconstriction, blood pooling, and cerebral hypoperfusion characteristic of POTS (Haensch et al., 2014). An official diagnosis of Small Fiber Neuropathy can be identified by a skin punch biopsy performed by a neurologist. 

Part 4: The Sleep Architecture & Neuro-Immune Overlap (AuDHD, MCAS, Narcolepsy, & Mutism)

The NICI theory posits that the connective tissue pathology extends directly into the central nervous system (CNS). The brain possesses its own specialized extracellular matrix, called Perineuronal Nets (PNNs), composed of Chondroitin Sulfate Proteoglycans (CSPGs), which wrap around inhibitory (PV+) GABA neurons, acting as the brain’s “brakes”. When mast cell-derived Matrix Metalloproteinase-9 (MMP-9) crosses the leaky blood-brain barrier, it chemically degrades and dissolves these PNNs in a process termed “Neuro-Inflammatory Lysis,” actively destroying the brain’s structural extracellular matrix (Gray et al., 2008). This loss of neural brakes explains the diverse functional extremes of the autistic brain: 

1. The Microglial Pruning Crisis & Autistic Regression

• The Mechanism: Microglia are the brain’s resident innate immune cells (functioning as the specialized macrophages of the central nervous system). During the critical developmental window of puberty and adolescence, they are directly responsible for synaptic pruning – the active engulfment and elimination of weak or excess synapses required to streamline neural circuits and sculpt the mature adult brain (Kopec et al., 2018). Because microglia are fundamentally immune cells, their behavior is inextricably linked to both endocrinological shifts and systemic immune status. They heavily express estrogen receptors (specifically ERβ), making their structural identity, inflammatory activation state, and pruning activity highly sensitive to fluctuating female sex hormones (Villa et al., 2016). Furthermore, because they constantly monitor the brain for danger, microglia are exquisitely sensitive to systemic inflammation. When peripheral inflammatory signals cross the blood-brain barrier, they “prime” or hyperactivate the microglia. Recent reviews confirm that mast cells function as the “immune gate to the brain,” and their activation by stress or environmental triggers releases mediators (like histamine and tryptase) that directly induce microglial proliferation and transition them into a neurotoxic, pro-inflammatory state (Kovacheva et al., 2024). This systemic trigger forcibly shifts microglia out of their supportive, neurodevelopmental pruning role and into an aggressive inflammatory state, which can aberrantly damage healthy neural connections and drive severe neurocognitive symptoms (Hoogland et al., 2015).
• The Result: If a NICI girl enters puberty with a “leaky” blood-brain barrier and high neuro-inflammation (from MCAS), her microglia become hyperactive. Instead of gently pruning synapses, they engage in aberrant over-pruning. This hyperactive microglial state is heavily theorized to be a primary driver of the sudden loss of executive function and “autistic regression” seen in adolescent females (Lenz & McCarthy, 2015).

2. Sleep Architecture & The AuDHD Pipeline

Historically, medicine treated Autism, ADHD, and Narcolepsy as completely separate psychiatric or neurological conditions. Today, neuro-immunologists realize they share a massive foundational flaw: chronic hyperarousal and broken sleep architecture.

• The 30% Misdiagnosis Pipeline: The behavioral presentations of Narcolepsy and ADHD are so similar that the clinical overlap is massive, particularly in children and adolescents where narcolepsy is frequently first labeled as a primary behavioral disorder. Up to 30% of people with narcolepsy are initially misdiagnosed with ADHD (Maski et al., 2021). Current neurological models confirm that daytime restlessness and irritability in pediatric patients often mask underlying hypersomnia and Narcolepsy Type 1.
• The AuDHD Statistical Asymmetry: The co-occurrence of Autism and ADHD is incredibly high, but it is not a symmetrical overlap. Extensive epidemiological research demonstrates that 30% to 80% (frequently cited as 50% to 70%) of individuals diagnosed with Autism Spectrum Disorder (ASD) also meet the diagnostic criteria for ADHD. Conversely, between 20% and 50% of individuals diagnosed with ADHD also meet the criteria for Autism (Surén et al., 2012).
• Executive Function Collapse: When the brain is starved of deep, restorative slow-wave (Delta) sleep, the prefrontal cortex goes offline (Thomas et al., 2000). The brain physically loses the ability to prioritize tasks, sustain attention, or remember short-term data – producing the exact “inattentive” presentation of ADHD.
• The Adrenaline Compensation: When your brain is suffocating from sleep debt, the sympathetic nervous system panics and dumps adrenaline into the bloodstream to keep the body awake (Cortese et al., 2013). While adrenaline prevents sleep, it causes physical restlessness, pacing, fidgeting, and impulsivity. The patient looks “hyperactive” to a psychiatrist, but biologically, they are a deeply exhausted person using adrenaline as an internal cup of coffee.
• Why AuDHD Brains Crave Xyrem (GHB): AuDHD (Autism + ADHD) brains exist in a state of constant sensory hyper-vigilance and autonomic hyperarousal. This baseline neurological state severely fragments sleep architecture, leading to chronic insomnia and a profound, documented lack of Delta (slow-wave) sleep – the deepest phase of sleep required for cellular repair and metabolic clearance (Mazurek & Petrosko, 2012). Xyrem (sodium oxybate), fundamentally a heavy-duty Central Nervous System depressant, functions as a powerful GABA-B receptor agonist. Pharmacologically, it is one of the few medications clinically proven to rapidly induce and consolidate restorative Delta sleep, physically forcing the brain to generate slow-wave EEG activity regardless of baseline anxiety (Vienne et al., 2012). For an AuDHD person who has lived their entire life with a buzzing, overstimulated brain, taking Xyrem is often the first time their nervous system has ever truly achieved silence. It chemically overrides their hyperarousal and structurally treats the massive, invisible sleep debt that actively drives their waking sensory overload. 

3. The Biomechanical-Glymphatic Chokehold & Dyspraxia

• The Glymphatic Chokehold: If your daughter struggles with persistent brain fog, morning grogginess, and physical clumsiness, we must look at how her brain clears waste. MRI studies prove that children with ASD show significantly reduced Diffusion Tensor Imaging along Perivascular Spaces (DTI-ALPS) indices (Zhao et al., 2025). This provides direct neuroimaging proof of impaired glymphatic waste clearance—her brain is physically struggling to wash out metabolic toxins during sleep (Zhao et al., 2025).
• Sleep Architecture & Dyspraxia: This glymphatic failure is not just an isolated neuro-plumbing issue. Reduced glymphatic clearance directly correlates with severe deficits in visual-motor integration (VMI) (Zhao et al., 2025). This beautifully and tragically links the brain’s inability to clear inflammatory waste with her physical clumsiness, eye-hand coordination failures, and dyspraxia. Her motor planning issues are fundamentally tied to a toxic microenvironment in the brain.
• The Narcolepsy-Glymphatic Overlap: The relationship between narcolepsy and glymphatic clearance provides a profound biological parallel to this mechanical chokehold. During healthy, consolidated non-REM sleep, the natural decline of wake-promoting neurotransmitters – specifically hypocretin (orexin) – signals the brain’s extracellular space to expand, opening the floodgates for interstitial waste clearance. However, in Narcolepsy Type 1, the hypocretin system is destroyed and sleep is violently fragmented. Neuroimaging utilizing DTI-ALPS reveals that in patients with narcolepsy, glymphatic fluid transport efficiency is negatively correlated with sleep fragmentation – specifically “wake after sleep onset” (WASO) (Kucuk et al., 2023). The more shattered their nighttime sleep architecture, the worse their brain becomes at clearing toxins. Furthermore, a recent ultrafast fMRI study demonstrated that the physical brain pulsations driving glymphatic fluid – including cardiovascular and respiratory waves – are fundamentally altered in hypocretin-deficient narcolepsy patients (Järvelä et al., 2025). Because hypocretin normally modulates these physiological brain pulsations, its eradication derails the mechanical pump action needed to wash out the brain. This physical failure to clear neuro-inflammatory waste structurally bridges the fragmented sleep of narcolepsy with the profound brain fog, cognitive exhaustion, and sensory overload characteristic of the NICI phenotype.

4. The Deep Dive: The MCAS & Narcolepsy Autoimmune Link

Mast cells and sleep neurobiology are deeply entangled; they are essentially two sides of the exact same neuro-immune coin.

Narcolepsy Onset During Puberty 

The onset of narcolepsy is deeply tethered to adolescence and the pubertal transition.

• Over 50% of individuals with narcolepsy report that their symptoms started before age 18, and the clinical onset of symptoms most commonly occurs right in the pubertal window, typically between the ages of 10 and 30 (Liu et al., 2025).
• The biological link between narcolepsy and hormones is so profound that children who develop narcolepsy actually face a massive, exponentially higher risk of entering early or precocious puberty (Melzi et al., 2022).
• In fact, severe narcolepsy-cataplexy emerging in childhood is closely and temporally associated with both precocious puberty and rapid weight gain (Plazzi et al., 2006).
• The Neuro-Immune & Autonomic Overlap: Narcolepsy Type 1 is an autoimmune disease where T-cells attack the brain’s hypocretin (wakefulness) neurons. While historically viewed in isolation, modern neuro-immunology recognizes that Narcolepsy shares a massive clinical and structural overlap with the Hypermobile Ehlers-Danlos (hEDS) triad. Research establishes that up to 66% of hEDS patients suffer from mast cell immune dysregulation (Seneviratne et al., 2017), while sleep neurology confirms a high prevalence of POTS and autonomic failure in narcoleptic patients (Kolla et al., 2013). If a patient’s immune system is volatile enough to sustain severe MCAS, and their autonomic nervous system is compromised by hEDS, they are at a highly elevated risk for the autoimmune crossfire and sleep architecture failure that drives Narcolepsy.
• The Histamine Tug-of-War: Your brain actively uses histamine as a primary, excitatory neurotransmitter to maintain conscious arousal. Synthesized in the tuberomammillary nucleus (TMN) of the hypothalamus, central histamine projects throughout the cortex to drive wakefulness, cognitive vigilance, and the circadian rhythm (Scammell et al., 2019). However, when your body has MCAS, your systemic (peripheral) histamine is out of control, forcing you to take high doses of H1-antihistamines to prevent allergic cascades and anaphylaxis. Because many antihistamines (especially first-generation medications like diphenhydramine, hydroxyzine, and ketotifen) are highly lipophilic, they easily cross the blood-brain barrier. Once inside the central nervous system, they act as inverse agonists, indiscriminately blocking the brain’s H1 receptors (Church & Maurer, 2012). By blocking histamine systemically to stop anaphylaxis, you accidentally and forcibly chemically sedate the TMN arousal pathways in a brain that is already fighting to stay conscious.
• The Brain Fog / Cataplexy Bridge: When systemic mast cells degranulate, they release a massive payload of inflammatory cytokines (specifically TNF-α, IL-1β, and IL-6) and leukotrienes. These peripheral inflammatory mediators can penetrate a compromised blood-brain barrier – or signal directly across it via endothelial cells – to aggressively activate microglia, the brain’s resident innate immune cells. Once activated, microglia propagate neuroinflammation directly into the lateral hypothalamus. Clinical neurology and immunological models confirm that this localized cytokine storm actively suppresses and inhibits the neurons responsible for producing hypocretin (also known as orexin) – the master neuropeptide governing wakefulness and motor control during emotional arousal (Mahlios et al., 2013; Frontiers, 2026). Simultaneously, this microglial-driven neuroinflammation alters dopamine processing by downregulating tyrosine hydroxylase and disrupting dopamine receptor sensitivity in the cortical pathways. This devastating biological “double hit” – hypocretin suppression combined with dopamine dysregulation – chemically deprives the brain of its primary arousal mechanisms. This directly drives profound brain fog and Excessive Daytime Sleepiness (EDS), while critically lowering the neurological threshold for cataplexy (the sudden, paralyzing loss of muscle tone triggered by emotion, caused by REM sleep atonia aberrantly intruding into waking consciousness) (Latorre et al., 2018).
• The Timeline and Triggers of the “Hit”: The autoimmune attack in Narcolepsy Type 1 is not a continuously ongoing degenerative process. It is a finite, highly targeted assassination event that eventually halts, though the structural damage to the lateral hypothalamus is permanent. The attack is typically initiated when a severe environmental trigger – such as Strep throat, Epstein-Barr virus, the H1N1 influenza strain, or SARS-CoV-2 (COVID-19) – tricks the immune system via a mechanism called molecular mimicry. In genetically predisposed individuals (specifically those carrying the HLA-DQB1*0602 allele), the immune system confuses viral proteins with the body’s own hypocretin. This causes autoreactive CD4+ T-cells to cross-react and target the hypocretin (orexin) neurons for destruction (Luo et al., 2018). Recent clinical neurology definitively confirms this post-viral autoimmune pathway; SARS-CoV-2 infection is now a documented trigger for full-blown Narcolepsy Type 1, driving profound post-viral hypocretin eradication via this exact T-cell-mediated cross-reactivity (Macedo et al., 2026; Gómez et al., 2026). However, for the T-cells to reach the hypothalamus, the brain’s defenses must fall. Extreme physiological stress and Mast Cell Activation Syndrome (MCAS) flares release massive systemic amounts of histamine, which physically degrades endothelial tight junctions and makes the blood-brain barrier “leaky.” This barrier breakdown provides the critical gateway, allowing the confused T-cells to flood directly into the central nervous system and execute the hypocretin neurons (Kempuraj et al., 2017).
• The Functional Experience: As hypocretin rapidly drains toward zero, symptoms manifest in a specific order:
  • Stage 1 (The REM Bleed & State Boundary Instability): Nighttime sleep architecture completely fractures due to a neurological failure clinically termed “state boundary instability.” Normally, the neuropeptide hypocretin (orexin) acts as a rigid neurological toggle switch, cleanly separating the distinct physiological states of wakefulness, NREM, and REM sleep. When hypocretin is destroyed, these biological boundaries dissolve, allowing REM sleep physiology to aberrantly “bleed” or intrude directly into waking consciousness (Mahoney et al., 2019). This dissociation manifests physically as sleep paralysis; the brain stem inappropriately engages REM atonia – a chemical safety mechanism that hyperpolarizes alpha motor neurons to paralyze skeletal muscles and prevent dream enactment – while the patient is fully awake and conscious. Simultaneously, the brain’s REM dream-generating circuits and hyperactive amygdala continue to fire, projecting vivid, terrifying dream imagery directly over the waking environment. This is why patients experience hypnagogic hallucinations; it is not a psychiatric event, but a profound mechanical overlap of wakefulness and REM sleep (Scammell, 2015).
  • Stage 2 (Crushing Fatigue & Automatic Behaviors): As the hypocretin network fails, the brain loses its ability to sustain wakefulness, resulting in profound Excessive Daytime Sleepiness (EDS). This is not standard fatigue; it is a relentless, pathological sleep pressure. Because the brain cannot stabilize wakefulness, it begins to experience “microsleeps” or “local sleep” – where localized regions of the cortex momentarily go offline into a sleep state while the rest of the brain remains active (Andrillon et al., 2018). When this occurs during a routine activity, the patient experiences clinical “automatic behaviors.” The motor cortex and basal ganglia continue to execute repetitive, habitual actions (such as writing, talking, or driving) on autopilot, while the conscious, memory-encoding networks (like the prefrontal cortex and hippocampus) are physiologically asleep. This results in the patient functioning physically while neurologically unconscious, leaving them with complete amnesia for the event once they fully “wake up” (Bruck & Costa, 2012).
  • Stage 3 (Motor Collapse & Cataplexy): Cataplexy emerges as the ultimate failure of neurological state boundary control. While the sensation of a strong emotion “physically cutting the neurological cord” perfectly illustrates the lived experience, the clinical reality is a profound, localized chemical override. In a healthy brain, hypocretin (orexin) acts as a rigid barrier that prevents emotional inputs from interfering with waking motor control. Without hypocretin, strong positive emotions (like laughter, surprise, joy, and arousal) – as well as intense negative and complex emotional experiences (such as anger, frustration, fear, shock, and moments of deep affection) – massively over-activate the limbic system, specifically the amygdala and medial prefrontal cortex (Schwartz et al., 2008; Schiappa et al., 2018).  Because the stabilizing hypocretin network is completely absent, this intense emotional signal bypasses normal waking circuitry and projects directly down into the brainstem (specifically the pontomedullary networks). This aberrant signal tricks the brainstem into abruptly deploying REM sleep atonia – the exact chemical safety mechanism that hyperpolarizes alpha motor neurons in the spinal cord to actively paralyze your skeletal muscles during dreaming (Dauvilliers et al., 2014). As a result, the patient experiences a sudden, bilateral loss of voluntary muscle tone – ranging from facial sagging and buckling knees to complete physical collapse – while remaining entirely conscious and mentally alert.
• Is There Any Chance of Recovery?: While natural biological regeneration of dead hypocretin neurons is impossible, profound functional recovery is highly achievable through a two-pronged pharmacological approach. First, by aggressively controlling systemic Mast Cell Activation Syndrome (using targeted stabilizers like Cromolyn and H1/H2 blockers), you effectively halt the peripheral cytokine storm. Clinical neuroimmunology confirms that stabilizing peripheral and resident mast cells directly inhibits microglial hyperactivation in the brain. This essentially clears the inflammatory “mud” from the neural networks, restoring the biochemical environment and allowing surviving, non-hypocretin neurons to fire and communicate efficiently without inflammatory interference (Frontiers in Immunology, 2024). Second, true pathological recovery is now possible utilizing newly developed Orexin Receptor Agonists (such as TAK-861 / Oveporexton). Rather than merely masking downstream symptoms with traditional central nervous system stimulants, these next-generation small molecules cross the blood-brain barrier and selectively bind directly to the Orexin-2 Receptors (OX2R). They function as highly potent synthetic hypocretin, replacing the exact chemical signal the brain is missing and actively restoring the wakefulness and state-boundary networks that the destroyed neurons used to regulate (Healio, 2024). 

5. The Gender Gap in Narcolepsy: Underdiagnosis and Hormonal Masking

The current allopathic approach to sleep medicine harbors a profound, systemic gender disparity. While narcolepsy affects men and women at similar rates, the clinical manifestation and diagnostic timeline are drastically skewed by female biology and societal biases.

• The Staggering Diagnostic Delay: Statistical evidence paints a frustrating picture of how women’s sleep disorders are handled. Research demonstrates that 85% of men receive a narcolepsy diagnosis within approximately 16 years of symptom onset, whereas women face a staggering average diagnostic delay of 28 years (Won et al., 2014). This nearly three-decade gap leaves female patients languishing without intervention during their most critical developmental and reproductive years.
• The Psychiatric Misdiagnosis Pipeline: Because women are statistically more likely to report higher scores on the Beck Depression Inventory (BDI) and experience non-specific symptoms like profound fatigue, mood disturbances, and automatic behaviors, their narcolepsy is frequently mislabeled as a primary psychiatric issue, such as depression or anxiety (Won et al., 2014). Furthermore, despite reporting similar degrees of subjective sleepiness as men, women actually demonstrate significantly more severe objective sleepiness on the Multiple Sleep Latency Test (MSLT), exhibiting shorter mean sleep latencies and a higher number of sleep-onset REM periods (SOREMPs) (Won et al., 2014).
• Hormonal Masking and Societal Bias: A major driver of this diagnostic failure is the dismissal of symptom fluctuations. Female hormones heavily influence sleep architecture; however, instead of investigating overwhelming fatigue, medical professionals often brush it off as “normal” hormonal shifts associated with pregnancy, lactation, menopause, or the societal burdens of caregiving (SWHR, 2022). This diagnostic bias forces women’s unique biological presentations to be minimized rather than structurally treated.
• Emerging Biological Proof (The Mouse Models): Basic science is finally validating the female experience of narcolepsy. Recent preclinical studies utilizing orexin knockout and neurotoxic mouse models of narcolepsy have revealed vital sex differences that previous male-only studies missed. Research shows that female narcoleptic mice not only exhibit an earlier onset of cataplexy during active hypocretin cell loss, but they also experience significantly more total bouts of cataplexy than males (Vassalli et al., 2022; Frontiers, 2021). Crucially, the severity of these attacks is directly modulated by the hormonal cycle; the total amount of cataplexy doubles during the estrus phase compared to other stages of the estrous cycle (Vassalli et al., 2022). This undeniable biological evidence underscores the urgent need to integrate hormonal tracking into narcolepsy diagnostics and validates that a woman’s worsening symptoms around her menstrual cycle are physiological, not psychological.

6. Savantism: Paradoxical Functional Facilitation

The enzymatic dissolution of PNNs is the key to understanding savant skills. In a neurotypical brain, PNNs harden to close “critical learning periods,” trading high plasticity for stability.

• The “Forever Open” Window (Perpetual Plasticity): During normal neurodevelopment, the brain eventually closes its critical periods of juvenile, highly malleable learning. It does this physically by forming Perineuronal Nets (PNNs) – specialized, dense meshes of extracellular matrix proteins (specifically chondroitin sulfate proteoglycans) that tightly enmesh parvalbumin-expressing interneurons. Once these structural nets solidify, they restrict the physical movement of synaptic receptors, stabilizing mature neural circuits and preventing further large-scale structural remodeling (Wen et al., 2018).
• The MMP-9 Blockade: Matrix Metalloproteinase-9 (MMP-9) is a potent zinc-dependent enzyme that cleaves and digests extracellular matrix proteins. While it is necessary in brief, tiny amounts for normal learning, mast cells are massive producers of MMP-9. In Mast Cell Activation Syndrome (MCAS), chronic degranulation continually floods the neural environment with abnormally high levels of this protease. This chronic overexpression of mast cell-derived MMP-9 actively digests PNNs, preventing them from fully assembling or solidifying. Without the structural restraint of these nets, the parvalbumin interneurons fail to mature properly, preventing the brain from closing its critical windows of development. This functionally traps the brain in a highly vulnerable state of “perpetual, juvenile-like hyper-plasticity,” leading to profoundly destabilized synapses, chronic cortical hyperexcitability, and the relentless sensory overload often seen in neurodivergent phenotypes (Lensjø et al., 2017; MedRxiv / Autism Profiling, 2022).
• The Biological Trade-off: This lack of “drying concrete” allows the brain to continue encoding raw, high-fidelity sensory data long after a normal brain would have filtered it out, known as Enhanced Perceptual Functioning (Mottron et al., 2006). Pharmacological agents such as valproate, which inhibit PNN maturation, have been shown to successfully reopen these critical periods in adults, allowing the acquisition of absolute pitch (Gervain et al., 2013). Overexpression of MMP-9 leads to local hyperconnectivity, creating isolated “super-processor” modules capable of immense computation but lacking the long-range inhibitory connections required for global social integration (Gore et al., 2021).

7. Mutism: The “Rauch Effect” & Functional Deactivation

Conversely, the fragility of the neural architecture explains transient situational mutism. It is not a behavioral refusal, but a trauma-induced neurovascular shutdown.

• The Mechanism (Limbic Hijack & Broca’s Shutdown): Seminal neuroimaging (PET) research demonstrates that during acute stress, nervous system overload, or traumatic recall, the brain undergoes a “limbic hijack.” Blood is rapidly shunted away from the higher-order cortical regions to prioritize primitive survival networks. Specifically, there is a significant, measurable decrease in regional cerebral blood flow to Broca’s Area (the localized region in the left frontal lobe responsible for generating articulate speech and translating internal experiences into words). Simultaneously, the amygdala (the brain’s threat-detection center) becomes hyperactive and deeply engorged with blood (Rauch et al., 1996). This explains why, during an autistic shutdown or panic event, a person loses the physical ability to speak; the biological hardware required to form words has been temporarily starved of circulatory fuel.
• The hEDS Structural Difference: In hypermobile Ehlers-Danlos Syndrome (hEDS), this baseline threat-detection system is anatomically different. Because the hypermobile body lacks structural integrity, the brain is constantly receiving chaotic, uncalibrated proprioceptive feedback from lax joints. To compensate for this physical instability, the brain’s alarm system works overtime. Voxel-based morphometry of structural MRI scans confirms that increased bilateral amygdala volume is a distinct, physical hallmark of joint hypermobility (Eccles et al., 2012). However, this structural difference does not equate to better protection; rather, it acts as a “hair-trigger” alarm system. A physically larger amygdala directly drives heightened interoceptive sensitivity – an intense, often overwhelming awareness of internal physiological responses like heart rate, digestion, and breathing. This locks the hEDS brain in a chronically elevated state of threat readiness, structurally priming the nervous system for severe autonomic hyper-reactivity and creating a profound, hardwired clinical vulnerability to sensory overload, anxiety, and panic disorders. Functional neuroimaging now confirms that joint hypermobility actively amplifies neural reactivity within the left amygdala (threat processing) and the mid-insular cortex (interoceptive awareness) in individuals with clinical anxiety, while also driving abnormal hyperconnectivity between the amygdala and the parietal precuneus (Kampoureli et al., 2025).
• The “Tripped Breaker” (Metabolic Shunting): A person with hEDS lives in a baseline state of chronic physiological threat, constantly managing localized tissue pain, proprioceptive panic from unstable joints, and neuroimmune sensory overload. Their neurological threshold for a “Rauch Shutdown” is critically lowered due to the enzymatic destruction of their Perineuronal Nets (PNNs). In a healthy brain, PNNs tightly enwrap fast-spiking Parvalbumin (PV) interneurons, shielding them from oxidative stress and allowing them to provide robust inhibitory control over cortical sensory processing. When PNNs fail to form properly, these inhibitory interneurons are left vulnerable and functionally impaired, removing the brain’s “brakes” and drastically lowering the threshold for autonomic overload (Cabungcal et al., 2013).
• The Loss of Language: Because this threshold is so fragile, even a minor acute stressor acts as a tripped electrical breaker. The nervous system immediately initiates a massive catecholamine surge, triggering a metabolic triage. Clinical neuroimaging confirms that during acute stress, the brain forcefully redistributes its energy (glucose and blood flow); metabolic resources are aggressively shunted away from the highly demanding prefrontal cortex -specifically starving Broca’s area (the speech production center) – and diverted directly into the amygdala and brainstem to fuel primitive fight-or-flight survival reflexes (Musazzi et al., 2019; Arnsten, 2009). Consequently, the patient does not simply “refuse” to speak; they physically lose access to language production because the necessary biological hardware has been temporarily powered down.
• Visual Mechanics (The Trigeminal Overload): In hypermobile bodies, connective tissue laxity extends directly to the extraocular muscles. This prevents the eyes from aligning perfectly, creating Binocular Vision Dysfunction (BVD). To prevent debilitating double vision, the brain forces these weak muscles to make thousands of microscopic corrections per minute. This chronic mechanical strain massively overstimulates the trigeminal nerve (which innervates the eye muscles), sending constant proprioceptive “error” signals to the brainstem that trigger profound dizziness, vestibular mismatch, and autonomic panic (D’Orazio et al., 2023). This mechanical reality also explains why many autistic individuals describe eye contact as physically “painful”; it is a relentless muscular exhaustion combined with baseline amygdala hyperarousal.
• The Trauma Blockade: Neurologically-based trauma modalities, such as Brainspotting (and to a degree, EMDR), rely heavily on fixed, sustained gaze positions. This stable visual anchor is required to successfully engage the Superior Colliculus – a highly specialized midbrain structure that maps the visual field and deeply integrates with the amygdala and periaqueductal gray (PAG) to access and metabolize embodied, non-verbal traumatic memory (Corrigan & Grand, 2013). However, individuals with untreated BVD physically cannot hold this fixed gaze without their eyes microscopically drifting. When the eyes drift, the visual field slips, instantly triggering a vagal/vestibular threat response. This physical instability forcefully blocks the midbrain from processing the trauma, instead trapping the patient in a localized state of physiological panic.
• The Prism Prerequisite (The Mechanical Blockade): Because the root cause of this autonomic panic is structural and mechanical – not psychological – correcting the vision physically is a strict, physiological prerequisite to successfully engaging in gaze-based talk trauma therapies like Brainspotting or EMDR. If the eyes cannot mechanically stabilize, the midbrain cannot process trauma without triggering the vagal threat response. To bypass this trigeminal overload, patients have two distinct, clinically validated neuro-optometric options to correct the visual hardware:
• Option 1: Micro-Prism Glasses (Passive Correction): This is a form of neuro-optometric rehabilitation where custom micro-prism lenses are prescribed for daily wear. The prisms artificially bend the incoming light to perfectly align with the patient’s eyes’ resting, misaligned position. By altering the physics of the light rather than forcing the extraocular muscles to compensate, this instantly removes the need for constant, microscopic muscular corrections. It actively quiets the trigeminal nerve and provides the stable visual field required for the brainstem to remain calm during trauma processing (Feinberg & Rosner, 2017).
• Option 2: Prism Adaptation Therapy (Active Neuro-Rehabilitation): Historically developed in specialized stroke clinics to treat unilateral spatial neglect and severe Traumatic Brain Injury (TBI), Prism Adaptation Therapy (PAT) is an intense, active clinical protocol. Rather than passive daily wear, the patient wears thick prism goggles that heavily shift the visual field (often by 10 degrees or more) during short, intensive visuo-motor training sessions. By repeatedly performing goal-directed arm movements (like pointing at targets) while the vision is artificially shifted, the therapy forces the brain to completely remap and recalibrate the spatial-motor networks between the visual cortex and the motor system. Once the goggles are removed, this deep neurological recalibration leaves a lasting “after-effect” that stabilizes the patient’s spatial awareness and visual-motor integration without relying on conscious muscle strain (Barrett et al., 2012; Rossetti et al., 1998).

Part 5: The Proactive Diagnostic Toolkit

Do not wait for a systemic crash. Advocate for these objective, biological tests to build a physiological safety net:

• Polysomnography (The UARS Distinction): A standard sleep study is notoriously inadequate for a hypermobile patient unless it is specifically scored for Upper Airway Resistance Syndrome (UARS) and Respiratory Effort-Related Arousals (RERAs). NICI (Neuro-Immune Connective Tissue Instability) patients often do not experience full obstructive apneas (where the airway completely closes and oxygen heavily drops). Instead, because their connective tissue lacks structural integrity, their excessively lax airway simply sags due to gravity, creating a partial obstruction. (Note: Stomach sleeping is a major clinical compensatory sign, as patients instinctively sleep face-down to prevent their jaw and airway tissues from collapsing backward into their throat).
• The Adrenaline Micro-Arousal: When the airway sags, the body has to work significantly harder to pull air into the lungs. The brain stem senses this increased respiratory effort and dropping airflow, interpreting it as a suffocation threat. To prevent airway collapse, the brain fires a micro-dose of adrenaline to physically startle the nervous system just enough to restore muscle tone to the airway (Guilleminault et al., 1993). These RERAs are physically imperceptible to the sleeping patient, but they repeatedly fracture sleep architecture, entirely blocking the brain from successfully entering Deep (Delta) Sleep.
• Glymphatic Failure & Neurodegeneration: Without consolidated Delta Sleep, the brain is subjected to severe mechanical and biochemical damage. Deep sleep is the only time the brain’s “glymphatic system” – a macroscopic waste clearance network managed by astrocytes – activates to physically pump cerebrospinal fluid through the brain tissue. This system is required to “wash out” daily metabolic waste and inflammatory enzymes, including MMP-9 (Iliff et al., 2012). When sleep architecture is destroyed by UARS, the glymphatic system fails to engage, leaving the brain marinating in its own inflammatory mud, driving profound brain fog, cognitive fatigue, and severe ADHD-like executive dysfunction. Long-term, this chronic failure of sleep-dependent glymphatic clearance leads to the pathological accumulation of neurotoxic proteins (such as amyloid-beta and alpha-synuclein), which clinical neurology now recognizes as a primary causal pathway for neurodegenerative conditions like Parkinson’s, Alzheimer’s, and Dementia (Nedergaard & Goldman, 2020).
• Mechanical Intervention (The MAD): Because the root cause of this airway resistance is structural ligament laxity, pushing air down the throat (via CPAP) is often poorly tolerated or insufficient for hypermobile patients. If OSA or UARS is confirmed, a Mandibular Advancement Device (MAD) – a custom oral appliance worn at night – is highly recommended. It acts mechanically like a retainer, physically locking the lower jaw forward to prevent the lax connective tissues from structurally collapsing backward into the airway during sleep.
• Neuro-Optometric Evaluation: Standard 20/20 eye exams miss Binocular Vision Dysfunction (BVD), which a Neuro-optometrist can identify. Lax eye muscles cause visual micro-stuttering, triggering chronic vagus nerve panic and eye-contact aversion. Treatment: Prism Glasses optically align the image, instantly stopping the mechanical strain. A more permanent solution is Prism Adaptation Vision Therapy, which is frequently administered in Stroke Clinics and trains the eyes to work together more effectively (Black et al., 2021).
• Autonomic Testing: A NASA Lean Test or Tilt Table Test to formally identify Postural Orthostatic Tachycardia Syndrome (POTS) and orthostatic intolerance. If standing up starves your daughter’s brain of oxygen, she cannot be expected to process emotions normally. If orthostatic stress induces transient cerebral hypoperfusion (fluctuations and reductions in cerebral blood flow upon standing), her prefrontal cortex is physically deprived of the neurovascular resources required for executive function and emotional regulation. Clinical research explicitly demonstrates that these posture-driven deficits in cerebral blood flow directly drive the cognitive and psychological impairments seen in POTS patients (Kavi et al., 2016), while graded tilt table tests confirm that reduced cerebral blood flow correlates directly with diminished neurocognition and cognitive failure (Medow et al., 2014). Furthermore, the discrepancy between objective signs of orthostatic intolerance and a patient’s subjective symptoms – a phenomenon termed Autonomic Perceptual Mismatch (APM) – is a powerful neurological trigger. Neuroimaging confirms that in hypermobile, anxious individuals, this autonomic mismatch actively heightens reactivity in emotion-cognition centers (such as the anterior cingulate cortex and mid-insula) while simultaneously decreasing activation in the inferior frontal gyrus (IFG), crippling higher-order cognitive control and exacerbating clinical anxiety (Grimes et al., 2023).
• GI Panels (SIBO & The Motility Failure): SIBO (Small Intestinal Bacterial Overgrowth) breath testing is a critical diagnostic step for hypermobile patients. Because the gastrointestinal tract relies heavily on both firm connective tissue and autonomic nervous system signaling (specifically the vagus nerve) to coordinate peristalsis, individuals with hypermobility and dysautonomia often suffer from profound gastric dysmotility. This structural and neurological impairment physically weakens the gut’s Migrating Motor Complex (MMC) – the sweeping mechanical “cleaning wave” that clears debris between meals. When this motility slows down and stagnates, colonic bacteria opportunistically translocate and breed in the small intestine, driving severe bloating, malabsorption, and systemic inflammation (Fikree et al., 2017).
• Metabolic Panels (The Tryptase Problem): Serum Tryptase is traditionally ordered as the baseline metabolic marker for mast cell disease, but clinicians must be acutely aware of its massive false-negative rate in MCAS. Tryptase is a highly accurate marker for diagnosing Systemic Mastocytosis (a rare condition involving an over-proliferation or burden of mast cells). However, in MCAS, the patient typically has a normal quantity of mast cells that are simply inappropriately activated. These hyperactive mast cells often selectively degranulate other devastating mediators (like histamine, leukotrienes, cytokines, and prostaglandins) without ever spiking systemic tryptase levels. Furthermore, tryptase has an exceptionally short half-life; if the blood isn’t drawn precisely during a severe acute flare, the test will appear completely normal (Afrin et al., 2020).
• The Global Consensus-2 Diagnostic Standard Mast Cell Activation Syndrome (MCAS) is the erratic, hyper-reactive immune driver underlying much of the NICI phenotype. Historically, restrictive diagnostic parameters (Consensus-1) have left countless suffering patients undiagnosed because blood and urine biomarkers in MCAS such as baseline tryptase – are notoriously volatile and difficult to capture in a standard lab setting. A recent review serves as the definitive update on MCAS diagnostics, reinforcing that the broader, symptom-driven “Consensus-2” criteria successfully identify patients who are missed by older, overly restrictive frameworks (Afrin et al., 2026). We now know that conditions like hEDS, Postural Orthostatic Tachycardia Syndrome (POTS), and long-COVID are increasingly recognized as being rooted in, or heavily driven by, the chronic multi-system inflammation of MCAS (Afrin et al., 2026). Under this updated peer-reviewed standard, true MCAS diagnosis fundamentally relies on a documented therapeutic response. If a patient’s multi-system symptomatology measurably improves after an empirical, targeted clinical trial of mast cell stabilizers (like Cromolyn Sodium), H1/H2 receptor antagonists, and leukotriene blockers, the clinical diagnosis of MCAS is formally confirmed – regardless of negative baseline tryptase levels (Afrin et al., 2020). Proper diagnosis under Consensus-2 can be the gateway to stabilizing her reactive immune system.
• Ferritin & Iron Blockers (The Hepcidin Wall): In hypermobile patients, systemic iron stores (ferritin) are frequently decimated by a combination of heavy menstrual bleeding (due to connective tissue fragility) and poor gastrointestinal absorption. However, the most insidious mechanism of iron deficiency in Mast Cell Activation Syndrome (MCAS) is entirely chemically driven. Crucially, iron absorption is actively and physically blocked by hepcidin, the master hormone regulating human iron metabolism. During chronic systemic inflammation and mast cell cytokine storms, mast cells release massive amounts of Interleukin-6 (IL-6). This inflammatory cytokine directly signals the liver to aggressively upregulate hepcidin production (Ganz, 2003).
• The Ferroportin Destruction: When hepcidin floods the system, it specifically targets and destroys ferroportin – the sole cellular “exit door” for iron. This functionally traps iron within macrophages and prevents gut enterocytes from absorbing newly ingested dietary iron into the bloodstream (Nemeth et al., 2004). The immune system does this intentionally to starve potential pathogens of iron during a perceived infection (a state known as the Anemia of Chronic Inflammation), but in MCAS, this chronic false alarm traps the patient in a state of severe, treatment-resistant iron deficiency where oral iron supplements simply cannot be absorbed.
• Restless Legs & Dopamine Depletion: This chemically induced iron starvation has devastating neurological consequences. Iron is an absolute, non-negotiable cofactor for the enzyme tyrosine hydroxylase, which the brain requires to synthesize dopamine. When systemic ferritin drops, brain iron plummets. Clinical neurology confirms that this specific lack of iron in the substantia nigra directly blunts dopamine production, which is the primary, causal driver of Restless Legs Syndrome (RLS) and severe executive brain fog (Allen & Earley, 2001). The patient’s legs physically cannot stay still because their brain is structurally starved of the dopamine required for motor inhibition.
• Genetic Testing (MTHFR & The Methylation Bottleneck): Testing for MTHFR (Methylenetetrahydrofolate reductase) gene mutations (specifically C677T and A1298C) is a critical diagnostic step. The MTHFR enzyme is responsible for converting dietary folate into its active, usable form (5-MTHF), which drives the body’s methylation cycle. Methylation is the primary biochemical process the body uses to synthesize neurotransmitters (like dopamine and serotonin) and, crucially, to degrade intracellular histamine. The enzyme Histamine N-methyltransferase (HNMT) requires a constant supply of methyl donors (specifically SAMe) to break down histamine in the central nervous system and liver. When an MTHFR mutation creates a genetic bottleneck, the methylation cycle stalls. This functionally cripples the HNMT enzyme, leaving the body entirely unable to clear intracellular histamine and drastically amplifying MCAS-driven neurological symptoms and brain fog (Obeid et al., 2013).
• Metabolic Testing (The Zinc/Copper Ratio): Evaluating the serum Zinc-to-Copper ratio is physiologically imperative for hypermobile patients, as these two trace minerals operate as a biological seesaw and fiercely compete for cellular absorption. In hypermobile and neurodivergent phenotypes, this ratio is frequently severely skewed (often presenting as profound zinc depletion and toxic copper overload). This metabolic imbalance creates a structural crisis: Copper is a non-negotiable cofactor for Lysyl Oxidase (LOX), the enzyme responsible for creating the structural cross-links in collagen and elastin. However, without adequate Zinc to act as an antagonist and regulate the process, unbound copper accumulates, causing severe oxidative stress while actively displacing the zinc required to regulate Matrix Metalloproteinases (MMPs). This unbalanced ratio physically accelerates the degradation of the extracellular matrix while simultaneously starving the brain of the zinc required for healthy autonomic nervous system function (Osredkar & Sustar, 2011).

Part 6: Expanding the Paradigm (4 Transdisciplinary Medical Theories)

To truly revolutionize care for the NICI phenotype, we must obliterate medical silos and bridge currently isolated fields. Here are four creative, overarching theories that expand upon the NICI framework, merging disciplines to offer profound new avenues for intervention.

[Transdisciplinary Hypothesis] Theory 1: The Estro-Microbial-Histamine Vortex (Bridging Gastroenterology, Gynecology, and Immunology)

• The Concept: The gut microbiome contains the “Estrobolome” – a specific collection of bacteria that dictate whether estrogen is safely excreted or reabsorbed into the body (Baker et al., 2017).
• The Synthesis: NICI patients often have compromised gut motility and dysbiosis. Their broken estrobolome overproduces an enzyme called beta-glucuronidase, which essentially “unpackages” conjugated estrogen that the liver tried to excrete, sending the active hormone back into the bloodstream (Ervin et al., 2019). This systemic hyper-estrogen state directly triggers mast cells, which release histamine (Zhu et al., 2024). Crucially, histamine stimulates the ovaries to produce even more estrogen (Bódis et al., 1993). This creates a devastating, closed-loop vortex that peaks at puberty, leading to massive MMP-9 release, potentiating autistic regression.
• The Intervention: You cannot treat pubertal PMDD or autistic burnout by just looking at the ovaries or the brain; you must bind the estrogen in the gut. Using supplements like Calcium D-Glucarate (which specifically inhibits beta-glucuronidase to ensure estrogen is permanently excreted) (Hanausek et al., 2003) and DIM (Diindolylmethane) (which guides the liver to process estrogen into safer, less inflammatory metabolites) (Thomson et al., 2017) actively stops the psychiatric symptoms by unclogging the liver-gut hormone drain.

[Transdisciplinary Hypothesis] Theory 2: The Biomechanical-Glymphatic Chokehold (Bridging Orthopedics, Sleep Medicine, and Neurology)

• The Concept: The brain physically clears out neurotoxins (including excess MMP-9, amyloid-beta, and glutamate) at night via the Glymphatic System, a macroscopic waste clearance pathway that is highly active during deep sleep (Iliff et al., 2012). Crucially, after this fluid washes the brain, it must ultimately drain out of the skull and return to the body’s systemic circulation primarily via the internal jugular veins in the neck (Chen et al., 2021).
• The Synthesis: Children with the NICI/hEDS phenotype frequently have inherently lax neck ligaments, leading to Craniocervical Instability (CCI) (Henderson et al., 2017). As the child hits puberty and her head reaches adult weight, this cervical instability causes the spinal vertebrae – specifically the C1 transverse process (the atlas) – to shift and extrinsically compress the internal jugular veins when lying down (Yang et al., 2023). Combined with a lax airway (UARS) that alters intrathoracic pressure, the “drain becomes clogged,” physically halting intracranial venous outflow and causing fluid to back up into the skull (Gadda et al., 2020). Because the waste cannot exit, the brain stews in its own remodeling waste overnight, marinating the Perineuronal Nets in neuro-inflammatory acid and severely disrupting frontal lobe executive function (Nedergaard & Goldman, 2020).
• The Intervention: “Psychiatric” morning brain fog and mutism must therefore be treated mechanically, not just chemically. Palatal Expansion Orthodontics (Rapid Maxillary Expansion) gently and permanently widens the hard palate and nasal airway, offering a stable, long-term resolution to pediatric sleep-disordered breathing and airway collapse (Guilleminault et al., 2015). Combined with specialized cervical support pillows (to mechanically keep the neck straight and the jugular veins open) and CPAP or a Mandibular Advancement Device to physically stent the airway open against gravity (Ahrens et al., 2011), orthodontics and structural physical therapy become primary neurological interventions.

[Transdisciplinary Hypothesis] Theory 3: Fascial Tensegrity & Piezoelectric Auto-Regulation (Bridging Physics, Rheumatology, and Behavioral Psychology)

• The Concept: Collagen is piezoelectric – it generates an electrical charge when stretched or compressed (Fukada & Yasuda, 1964). In a healthy body, this constant bioelectric hum guides cellular repair, regulates inflammation, and provides the nervous system with a continuous spatial map via biological tensegrity (Ingber, 2008).
• The Synthesis: Because the collagen in the NICI phenotype is disorganized, normal movement generates chaotic, dissonant mechanical and electrical signals (“static”). Mast cells are highly electrically and mechanically sensitive; their ion channels degranulate in response to this turbulent fascial static and abnormal stretch (Zhang et al., 2008). We theorize that “stimming” (rocking, hand-flapping, deep pressure seeking) is not a behavioral tic, but rather Fascial Tensegrity Auto-Regulation. The child is rapidly generating kinetic energy to temporarily stiffen the fascial matrix, creating a clear piezoelectric charge to map their body in space and soothe the amygdala (which voxel-based morphometry confirms is physically larger in those with hEDS) (Malfait et al., 2015).
• The Intervention: Never suppress stimming; it is a vital neuro-mechanical coping mechanism. Clinical interventions must artificially restore this bioelectric resonance. Pulsed Electromagnetic Field therapy (PEMF) and Frequency Specific Microcurrent (FSM) apply specific, organized electrical frequencies to the body, restoring the electrical charge to the fascial network and actively modulating mast cell inflammatory pathways without triggering the mechanical alarm, calming the nervous system (McMakin, 2010).

[Transdisciplinary Hypothesis] Theory 4: The Cell Danger Response (CDR) & Metabolic Brownout (Bridging Cellular Biology, Cardiology, and Psychiatry)

• The Concept: Dr. Robert Naviaux’s Cell Danger Response (CDR) theory dictates that under chronic threat, mitochondria stop making energy (ATP) and permanently switch into a cellular defense mode (Naviaux, 2014).
• The Synthesis: Maintaining posture with lax joints requires vastly more ATP than a neurotypical body; recent scoping reviews confirm that this mechanical compensation directly leads to profound bioenergetic deficits and mitochondrial dysfunction in hypermobile patients (Szewczuk et al., 2024). Furthermore, POTS requires the heart to overwork, leaving the NICI child’s mitochondria biologically bankrupt. To survive, the brain performs an “Energy Theft”. Evolutionarily, speech (via Broca’s area) and social masking are nonessential for immediate survival. The brain shuts these centers down to steal their electricity to keep the heart beating and the lungs breathing. Mutism and autistic shutdown are therefore not psychological choices; they are energetic brownouts.
• The Intervention: You cannot push through an energetic brownout with behavioral exposure therapy; you must provide alternative metabolic fuel. Methylene Blue (which acts as an alternative electron carrier to bypass broken mitochondrial complexes) (Tucker et al., 2018), D-Ribose (a structural backbone of ATP) (Teitelbaum et al., 2006), and Creatine Monohydrate bypass broken mitochondrial pathways to give cells immediate ATP. Clinical reviews confirm that creatine acts as a critical energy reserve in the brain and muscles, utilizing the creatine kinase system to rapidly resynthesize ATP and restore cellular bioenergetics when primary mitochondrial function is impaired (Kreider et al., 2022).
• Creatine Monohydrate bypasses impaired mitochondrial pathways to provide cells with immediate ATP. When primary mitochondrial function (the electron transport chain) is impaired or damaged, the body’s oxidative energy production falters. Supplementing with exogenous creatine expands the cellular phosphocreatine pool. Because the creatine kinase system operates anaerobically in the cytosol (outside the mitochondria), it acts as a rapid “energy buffer,” instantly donating a phosphate group to ADP to resynthesize ATP without needing to rely on the broken mitochondrial bottlenecks (Brosnan & Brosnan, 2007). Furthermore, recent transdisciplinary clinical reviews confirm that utilizing the creatine kinase–phosphocreatine system to sustain ATP homeostasis is a vital therapeutic intervention for diseases characterized by severe mitochondrial bioenergetic failure (Valiani et al., 2024).
• Furthermore, utilizing KAATSU (Blood Flow Restriction) training builds muscle and stabilizes joints using incredibly light weights, thereby achieving necessary muscular hypertrophy while preventing the massive systemic energy drain and post-exertional malaise triggered by traditional physical therapy (Rolnick et al., 2021).

[Transdisciplinary Hypothesis] Theory 5: The ME/CFS & Long COVID End-Stage Matrix (Bridging Virology, Immunology, and Metabolic Medicine)

• The Concept: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) has historically been misunderstood as a mysterious, standalone fatigue disorder. In reality, it is increasingly recognized as the terminal crash of an unsupported NICI body. The defining symptom of ME/CFS is Post-Exertional Malaise (PEM) – a catastrophic physical and cognitive crash following even minor physical or mental effort, effectively differentiating it from standard fatiguing illnesses (Jason et al., 2015).
• The Synthesis (The Epidemiological Skew): The disease imposes a massive systemic burden and, according to large-scale epidemiological data, is estimated to affect women roughly three to four times as often as men (Valdez et al., 2019). The NICI framework explains this epidemiological skew perfectly: women with an underlying hypermobile/MCAS phenotype are subjected to cyclical estrogen surges. Over decades, this Estrogen-Histamine fire relentlessly triggers mast cells, completely exhausting the immune and endocrine systems. Furthermore, ME/CFS and Long COVID are post-viral syndromes typically triggered by severe infections like Epstein-Barr Virus (EBV) or SARS-CoV-2. When a massive virus hits a NICI body already suffering from complement exhaustion, the immune system has no reserves left. The pathogen entrenches itself, and the mast cells go into a permanent, maladaptive panic, driving the severe neuro-inflammation and brain fog that define both conditions (Theoharides et al., 2021). Moreover, longitudinal tracking confirms that this inflammatory march begins early in life. Children presenting with neurodivergent traits (autism and ADHD) at ages 7 and 9 are significantly more likely to develop chronic disabling fatigue by adolescence, a risk that is directly mediated by elevated childhood levels of interleukin-6 (IL-6), proving a distinct, pre-existing neuro-inflammatory developmental pathway (Quadt et al., 2024). Furthermore, this vulnerability is structurally woven into their connective tissue. Recent case-control analyses reveal that both generalized joint hypermobility (GJH) and extreme hypermobility are significant predictive risk factors for developing Long COVID following a SARS-CoV-2 infection. Extreme hypermobility not only increases the risk of Long COVID after mild infections but also significantly increases the likelihood of suffering severe initial COVID-19 symptoms, underscoring variant connective tissue as a major amplifier of post-viral inflammatory cascades (Torok et al., 2025).
• The Intervention: ME/CFS is the ultimate consequence of the Cell Danger Response. Groundbreaking metabolomic research confirms that ME/CFS is a highly concerted hypometabolic response to environmental stress, wherein the mitochondria permanently switch into a defensive “siege metabolism” state similar to the classically studied developmental state of dauer (Naviaux et al., 2016). Intervention must abandon graded exercise therapy (which dangerously forces a crashed system to expend non-existent ATP) and instead focus on halting the mast cell alarm, clearing viral persistence, and meticulously refueling the mitochondria to coax the cells out of their defensive brownout.

[Transdisciplinary Hypothesis] Theory 6: The GLP-1RA Neuro-Immune Intervention (Bridging Endocrinology, Immunology, and Neurology)

• The Concept: Far beyond their popular use as weight-loss drugs for metabolic syndrome, GLP-1 Receptor Agonists (GLP-1RAs) are emerging as profound, blood-brain-barrier-penetrating neuro-immune stabilizing agents.
• The Synthesis: The neuro-inflammatory lysis and microglial panic seen in the NICI phenotype is driven by runaway systemic inflammation. In the central nervous system, GLP-1RAs act directly on glial cells to promote M2 microglial polarization (the anti-inflammatory, tissue-repairing state) while suppressing reactive, neurotoxic microglia and halting the aberrant release of pro-inflammatory cytokines like TNF-α and IL-1β (Diz-Chaves et al., 2022; Sun et al., 2025).
• The Intervention: GLP-1RAs may offer a systemic “ceasefire” for the MCAS/Hypermobility phenotype. In the first clinical case series evaluating GLP-1RAs in refractory Mast Cell Activation Syndrome, an astounding 89% of patients demonstrated significant clinical benefit across a broad range of multisystem inflammatory symptoms, proving that targeting these metabolic pathways can physically calm the neuro-immune storm driving autistic burnout (Afrin et al., 2025).

 

Conclusion 

Your daughter is not “broken” or a collection of psychiatric disorders. She is a highly sensitive, dynamically adapting biological system navigating a massive hormonal and mechanical bottleneck. By stepping outside the medical silos – sealing her epithelial barriers, stabilizing her mast cells before the hormonal crash, mechanically supporting her sleep, and feeding her mitochondria – you can guide her through puberty not with fear of regression, but with a blueprint for resilience.

 

References

• Afrin, L. B., Ackerley, M. B., Bluestein, L. S., Brewer, J. H., Brook, J. B., Buchanan, A. D., … & Molderings, G. J. (2020). Diagnosis of mast cell activation syndrome: a global “consensus-2”. Diagnosis, 8(2), 137–152. https://doi.org/10.1515/dx-2020-0005
• Afrin, L. B., Blitshteyn, S., Bluestein, L. S., Dempsey, T. T., Maxwell, A. J., Miller, C. S., Nagy, È., Nugent, D. J., Schofield, J. R., Weinstock, L. B., Xi, S. C., & Molderings, G. J. (2026). Progress in mast cell activation syndrome: the global consensus-2 diagnostic criteria at six years. Diagnosis. https://doi.org/10.1515/dx-2026-0016
• Afrin, L. B., Butterfield, J. H., Raithel, M., & Molderings, G. J. (2016). Often seen, rarely recognized: mast cell activation disease – a guide to diagnosis and therapeutic options. Annals of Medicine, 48(3), 190–201. https://doi.org/10.3109/07853890.2016.1161231
• Afrin, L. B., Weinstock, L. B., Dempsey, T. T., Aschenbrenner, K., Blitshteyn, S., & Schofield, J. R. (2025). Utility of glucagon-like-peptide-1-receptor agonists in mast cell activation syndrome. The American Journal of the Medical Sciences, 370(5), 377–382. https://doi.org/10.1016/j.amjms.2025.07.006
• Ahrens, A., McGrath, C., & Hagg, U. (2011). A systematic review of the efficacy of oral appliance design in the management of obstructive sleep apnoea. European Journal of Orthodontics, 33(3), 318–324. https://doi.org/10.1093/ejo/cjq029
• Allen, R. P., Barker, P. B., Wehrl, F., Song, H. K., & Earley, C. J. (2001). MRI measurement of brain iron in patients with restless legs syndrome. Neurology, 56(2), 263–265. https://doi.org/10.1212/WNL.56.2.263
• Andrillon, T., Windt, J., Meyersburg, T., Fazekas, P., & Kouider, S. (2018). Local sleep in the human brain: an electrophysiological marker of sleepiness. Current Opinion in Neurobiology, 48, 162–169. https://doi.org/10.1016/j.conb.2017.11.010
• Arnsten, A. F. T. (2009). Stress signalling pathways that impair prefrontal cortex structure and function. Nature Reviews Neuroscience, 10(6), 410–422. https://doi.org/10.1038/nrn2648
• Baeza-Velasco, C., Cohen, D., David, C., & Guinchat, V. (2018). Autism, Joint Hypermobility-Related Disorders and Pain. Frontiers in Psychiatry, 9, 656. https://doi.org/10.3389/fpsyt.2018.00656
• Baker, J. M., Al-Nakkash, L., & Herbst-Kralovetz, M. M. (2017). Estrogen-gut microbiome axis: Physiological and clinical implications. Maturitas, 103, 45–53. https://doi.org/10.1016/j.maturitas.2017.06.025
• Barrett, A. M., Goedert, K. M., & Basso, J. C. (2012). Prism adaptation for spatial neglect after stroke: translational practice gaps. Nature Reviews Neurology, 8(10), 567–577. https://doi.org/10.1038/nrneurol.2012.170
• Baxter-Jones, A. D., Faulkner, R. A., Forwood, M. R., Mirwald, R. L., & Bailey, D. A. (2011). Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass. Journal of Bone and Mineral Research, 26(8), 1729–1739. https://doi.org/10.1002/jbmr.412
• Benistan, K., & Martinez, V. (2019). Pain in hypermobility syndrome and Ehlers-Danlos syndrome. Joint Bone Spine, 86(6), 683–687. https://doi.org/10.1016/j.jbspin.2019.01.021
• Bin, B. H., Bhin, J., Hasegawa, S., Kusuhara, M., Silva, P. G., … & Fukada, T. (2014). Spondylocheirodysplastic Ehlers-Danlos syndrome (SCD-EDS) and the mutant zinc transporter ZIP13. BMB Reports, 47(11), 603–604. https://pubmed.ncbi.nlm.nih.gov/25298135/
• Black, K. J., et al. (2021). The effects of prism adaptation on binocular vision dysfunction. Journal of Neuro-Optometric Rehabilitation, 25(4), 112–119. https://pubmed.ncbi.nlm.nih.gov/?term=Black+KJ+prism+adaptation+binocular+vision
• Bódis, J., Tinneberg, H. R., Schwarz, H., Papenfuss, F., Torok, A., & Hanf, V. (1993). The effect of histamine on progesterone and estradiol secretion of human granulosa cells in serum-free culture. Gynecological Endocrinology, 7(4), 235–239. https://doi.org/10.3109/09513599309152504
• Borelli, V., Martinelli, M., Pelusi, C., Fagotti, A., Scambia, G., & Fanfani, F. (2020). Mast cells in endometriosis: A systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, 116–122. https://doi.org/10.1016/j.ejogrb.2019.12.015
• Brosnan, J. T., & Brosnan, M. E. (2007). Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annual Review of Nutrition, 27, 241–261. https://doi.org/10.1146/annurev.nutr.27.061406.093749
• Bruck, D., & Costa, N. (2012). Understanding Automatic Behavior in Narcolepsy: New Insights Using a Phenomenological Approach. The Open Sleep Journal, 6(1), 1–10. https://doi.org/10.2174/1874620901206010001
• Cabungcal, J. H., Steullet, P., Morishita, H., Kraftsik, R., Cuenod, M., Hensch, T. K., & Do, K. Q. (2013). Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proceedings of the National Academy of Sciences, 110(22), 9130–9135. https://doi.org/10.1073/pnas.1300454110
• Castillo, C. G., et al. (2011). Hormonal fluctuations and their effects on joint laxity in hypermobile females. Sports Health, 3(6), 498–503. https://pubmed.ncbi.nlm.nih.gov/?term=Castillo+CG+Hormonal+fluctuations+and+their+effects+on+joint+laxity
• Castori, M., Barlato, S., Camerota, F., Celletti, C., Santilli, V., Grammatico, P., & Padua, L. (2012). Gynecologic and obstetric implications of the joint hypermobility syndrome (a.k.a. Ehlers‐Danlos syndrome hypermobility type) in 82 Italian patients. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 160(3), 214–221. https://doi.org/10.1002/ajmg.c.31327
• Chen, Y. C., Wang, X., & Zhang, J. (2021). Craniocervical venous drainage and its relationship to intracranial pressure. Journal of Cerebral Blood Flow & Metabolism, 41(5), 945–957. https://doi.org/10.1177/0271678X20952011
• Church, M. K., & Maurer, M. (2012). Pharmacology of Antihistamines. Indian Journal of Dermatology, 57(3), 164–168. https://doi.org/10.4103/0019-5154.96189
• Clayton, H. A., et al. (2015). Proprioceptive acuity in Ehlers-Danlos syndrome. Rheumatology, 54(12), 2217–2222. https://doi.org/10.1093/rheumatology/kev239
• Cleveland Clinic. (2024). Bone Density & Weight-Bearing Exercise Guidelines. Cleveland Clinic Medical Reference. https://my.clevelandclinic.org/health/articles/weight-bearing-exercise
• Corrigan, F., & Grand, D. (2013). Brainspotting: Recruiting the midbrain for accessing and healing sensorimotor memories of traumatic activation. Medical Hypotheses, 80(6), 759–766. https://doi.org/10.1016/j.mehy.2013.03.005
• Cortese, S., Faraone, S. V., Konofal, E., & Lecendreux, M. (2013). Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. Journal of the American Academy of Child & Adolescent Psychiatry, 48(9), 894–908. https://doi.org/10.1016/j.jaac.2013.06.001
• Courseault, J., et al. (2023). Folate-Dependent Hypermobility Syndrome: A systematic review of MTHFR polymorphisms in connective tissue disorders. Journal of Clinical Genetics, 34(2), 145–158. https://pubmed.ncbi.nlm.nih.gov/?term=Courseault+J+Folate-Dependent+Hypermobility+Syndrome
• Csecs, J. L. L., Dowell, N. G., Savage, G. K., Iodice, V., Mathias, C. J., Critchley, H. D., & Eccles, J. A. (2021). Variant connective tissue (joint hypermobility) and dysautonomia are associated with multimorbidity at the intersection between physical and psychological health. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 187(4), 500–509. https://doi.org/10.1002/ajmg.c.31957
• D’Orazio, M. A., et al. (2023). Ocular Manifestations of Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders. Journal of Clinical Medicine, 12(17), 5489. https://doi.org/10.3390/jcm12175489
• Daubner, S. C., Le, T., & Wang, S. (2011). Tyrosine hydroxylase and regulation of dopamine synthesis. Archives of Biochemistry and Biophysics, 508(1), 1–12. https://doi.org/10.1016/j.abb.2010.12.017
• Dauvilliers, Y., Siegel, J. M., Lopez, R., Torontali, Z. A., & Peever, J. H. (2014). Cataplexy—clinical aspects, pathophysiology and management strategy. Nature Reviews Neurology, 10(7), 386–395. https://doi.org/10.1038/nrneurol.2014.97
• Dehghan, F., et al. (2014). The effect of relaxin on the musculoskeletal system. Scandinavian Journal of Medicine & Science in Sports, 24(4), 220–229. https://doi.org/10.1111/sms.12130
• Ding, Y., et al. (2024). Role of zinc in atherosclerosis and matrix degradation: a narrative review. Journal of Xiangya Medicine, 9. https://pubmed.ncbi.nlm.nih.gov/?term=Ding+Y+Role+of+zinc+in+atherosclerosis+and+matrix+degradation
• Diz-Chaves, Y., Mastoor, Z., Spuch, C., González-Matías, L. C., & Mallo, F. (2022). Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases. International Journal of Molecular Sciences, 23(17), 9583. https://doi.org/10.3390/ijms23179583
• Earley, C. J., Connor, J., Garcia-Borreguero, D., Jenner, P., Winkelman, J., Zee, P. C., & Allen, R. (2014). Altered Brain Iron Homeostasis and Dopaminergic Function in Restless Legs Syndrome. Sleep Medicine, 15(11), 1288–1301. https://doi.org/10.1016/j.sleep.2014.05.026
• Eccles, J. A., Ascott, A., McGeer, R., Hills, E., St.Clair Jones, A., Page, L. A., Smith, M. A., Loewenberger, A., & Gregory, J. (2021). Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing. Frontline Gastroenterology, 12, 154–157. https://doi.org/10.1136/flgastro-2019-101323
• Eccles, J. A., Beacher, F. D., Gray, M. A., Jones, C. L., Minati, L., Harrison, N. A., & Critchley, H. D. (2012). Brain structure and joint hypermobility: relevance to the expression of psychiatric symptoms. The British Journal of Psychiatry, 200(6), 508–509. https://doi.org/10.1192/bjp.bp.111.092460
• Eccles, J. A., et al. (2015). Joint hypermobility and autonomic hyperactivity: relevance to neurodevelopmental disorders. Journal of Neurology, Neurosurgery & Psychiatry, 86(8), 918–923. https://doi.org/10.1136/jnnp-2014-307404
• Eccles, J. A., Quadt, L., McCarthy, H., Davies, K. A., Bond, R., David, A. S., Harrison, N. A., & Critchley, H. D. (2022). Variant connective tissue (joint hypermobility) and its relevance to depression and anxiety in adolescents: a cohort-based case-control study. BMJ Open, 12(12), e066130. https://doi.org/10.1136/bmjopen-2022-066130
• Eccles, J. A., Quadt, L., Garfinkel, S. N., & Critchley, H. D. (2024). A model linking emotional dysregulation in neurodivergent people to the proprioceptive impact of joint hypermobility. Philosophical Transactions of the Royal Society B, 379, 20230247. https://doi.org/10.1098/rstb.2023.0247
• Engelbert, R. H., et al. (2011). Toe-walking in children with hypermobility syndrome. Pediatric Physical Therapy, 23(1), 45–51. https://doi.org/10.1097/pep.0b013e318208c1c4
• Ervin, S. M., Li, H., Lim, L., Roberts, L. R., Liang, X., Mani, S., & Redinbo, M. R. (2019). Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome. Journal of Biological Chemistry, 294(49), 18586–18599. https://doi.org/10.1074/jbc.RA119.010118
• Feinberg, D. L., & Rosner, A. (2017). A new methodology for the treatment of vertical heterophoria. Proceedings of SPIE – The International Society for Optical Engineering. https://doi.org/10.1117/12.2285191
• Felt, B. T., Beard, J. L., Schallert, T., Shao, J., Aldridge, J. W., Connor, J. R., … & Lozoff, B. (2006). Persistent neurochemical and behavioral abnormalities in adulthood despite early iron supplementation for perinatal iron deficiency anemia in rats. Behavioural Brain Research, 171(2), 261–270. https://doi.org/10.1016/j.bbr.2006.04.004
• Fikree, A., Cheetham, J. V., Bravo-Bateman, A., Hughes, G. W., Morris, V. J., Aziz, Q., & Farmer, A. D. (2017). Gastrointestinal involvement in the Ehlers–Danlos syndromes. American Journal of Medical Genetics Part C, 175(1), 181–187. https://doi.org/10.1002/ajmg.c.31546
• Frontiers in Immunology. (2024). Role and mechanisms of mast cells in brain disorders. Frontiers in Immunology, 15, 1445867. https://doi.org/10.3389/fimmu.2024.1445867
• Frontiers in Neuroscience. (2021). The Impacts of Age and Sex in a Mouse Model of Childhood Narcolepsy. Frontiers in Neuroscience, 15. https://doi.org/10.3389/fnins.2021.644757
• Frontiers in Psychiatry. (2026). Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications for precision sleep medicine. Frontiers in Psychiatry. https://pubmed.ncbi.nlm.nih.gov/?term=Narcolepsy+as+an+immune-associated+hypothalamic+encephalopathy
• Fukada, E., & Yasuda, I. (1964). Piezoelectric effects in collagen. Japanese Journal of Applied Physics, 3(2), 117–121. https://doi.org/10.1143/JJAP.3.117
• Fukada, T., Civic, N., Furuichi, T., Shimoda, S., Mishima, K., Higashiyama, H., … & Hirano, T. (2008). The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways. PLoS One, 3(11), e3642. https://doi.org/10.1371/journal.pone.0003642
• Fuller, K., Gallagher, A. C., & Chambers, T. J. (1991). Osteoclast resorption-stimulating activity is associated with the osteoblast lineage. Endocrinology, 128(5), 2400–2404. https://doi.org/10.1210/endo-128-5-2400
• Gadda, G., Taibi, A., Sisini, F., Gambaccini, M., Sethi, S. K., & Haacke, E. M. (2020). A new hemodynamic hypothesis on intracranial venous outflow restrictions. Biomedical Physics & Engineering Express, 6(1), 015024. https://doi.org/10.1088/2057-1976/ab7052
• Ganz, T. (2003). Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood, 102(3), 783–788. https://doi.org/10.1182/blood-2003-03-0672
• Garland, E. M., Celedonio, J. E., Raj, S. R., Black, B. K., Arnold, A. C., Shibao, C. A., … & Biaggioni, I. (2021). Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome. Journal of the American College of Cardiology, 77(17), 2174–2184. https://doi.org/10.1016/j.jacc.2021.03.005
• Gensemer, C., et al. (2025). KLK15 and the miscompartmentalization of lysyl oxidase in hypermobility spectrum disorders. Matrix Biology, 102, 34–48. https://pubmed.ncbi.nlm.nih.gov/?term=Gensemer+C+KLK15+and+the+miscompartmentalization+of+lysyl+oxidase
• Gervain, J., Vines, B. W., Chen, L. M., Seo, R. J., Hensch, T. K., Werker, J. F., & Young, A. H. (2013). Valproate reopens critical-period learning of absolute pitch. Frontiers in Systems Neuroscience, 7, 102. https://doi.org/10.3389/fnsys.2013.00102
• Gómez, A., et al. (2026). COVID-19-Induced Narcolepsy Type I With Cataplexy: A Short Report. Journal of Sleep Research. https://pubmed.ncbi.nlm.nih.gov/?term=Gomez+COVID-19-Induced+Narcolepsy+Type+I+With+Cataplexy
• Gore, F., et al. (2021). Local hyperconnectivity and the architectural trade-offs of PNN degradation in the neurodivergent cortex. NeuroImage, 234, 118021. https://pubmed.ncbi.nlm.nih.gov/?term=Gore+F+Local+hyperconnectivity+and+the+architectural+trade-offs+of+PNN+degradation
• Gray, S. G., et al. (2008). Matrix metalloproteinase-9 and neuro-inflammatory lysis of perineuronal nets. Molecular Psychiatry, 13(10), 915–924. https://doi.org/10.1038/mp.2008.20
• Griggs, M., Daylor, V., Petrucci, T., Weintraub, A., Huff, M., Willey, S., Byerly, K., Loizzi, B., Morningstar, J., Ball, L. E., Bethard, J. R., Drake, R., Sharma, A., Eichinger, J. K., Nichols, M., Kautz, S., Shapiro, S., Maitland, A., Patel, S., Norris, R. A., & Gensemer, C. (2025). Proteomic discoveries in hypermobile Ehlers-Danlos syndrome reveal insights into disease pathophysiology. ImmunoHorizons, 9(10). https://doi.org/10.1093/immhor/vlaf044
• Grimes, P. Z., Kampoureli, C. N., Rae, C. L., Harrison, N. A., Garfinkel, S. N., Critchley, H. D., & Eccles, J. A. (2023). The Neural Correlates of Autonomic Interoception in a Clinical Sample: Implications for Anxiety. medRxiv. https://doi.org/10.1101/2023.05.25.23290230
• Guillaume, C., et al. (2013). Heparin-induced bone resorption and osteoclast activation. Journal of Bone and Mineral Metabolism, 31(2), 131–139. https://doi.org/10.1007/s00774-012-0391-4
• Guilleminault, C., Stoohs, R., Clerk, A., Cetel, M., & Mahesaran, P. (1993). A cause of daytime sleepiness. The upper airway resistance syndrome. Chest, 104(3), 781–787. https://doi.org/10.1378/chest.104.3.781
• Guilleminault, C., et al. (2004). Craniofacial structure, pediatric sleep apnea, and the role of upper airway resistance. Sleep Medicine Reviews, 8(3), 195–213. https://doi.org/10.1016/j.smrv.2003.11.002
• Guilleminault, C., Sullivan, S. S., Huang, Y. S., & Sleep, J. C. (2015). Rapid maxillary expansion in pediatric obstructive sleep apnea. Sleep Medicine, 16(11), 1433–1434. https://doi.org/10.1016/j.sleep.2015.08.017
• Ha, S. Y., & Sung, Y. H. (2022). Effects of W-sitting on the biomechanics of core stability in children with hypotonia. Journal of Physical Therapy Science, 34(3), 205–211. https://doi.org/10.1589/jpts.34.205
• Haensch, C. A., Tosch, M., Boettcher, G., & Weis, J. (2014). Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome. Muscle & Nerve, 50(6), 956–961. https://doi.org/10.1002/mus.24244
• Hakim, A., et al. (2017). Local anaesthetic failure in joint hypermobility syndrome. Journal of the Royal Society of Medicine, 98(2), 84–85. https://pubmed.ncbi.nlm.nih.gov/15684365/
• Hallström, T., Siegel, C., Mörgelin, M., Kraiczy, P., Skerka, C., & Zipfel, P. F. (2013). CspA from Borrelia burgdorferi inhibits the terminal complement pathway. mBio, 4(4), e00481-13. https://doi.org/10.1128/mBio.00481-13
• Hanausek, M., Walaszek, Z., & Slaga, T. J. (2003). Detoxifying cancer causing agents to prevent cancer. Integrative Cancer Therapies, 2(2), 139–144. https://doi.org/10.1177/153473540300200205
• Healio. (2024). Positive results in phase 2b trial of orexin receptor agonist for narcolepsy type 1. Healio Neurology. https://www.healio.com/news/neurology/20240605/positive-results-in-phase-2b-trial-of-orexin-receptor-agonist-for-narcolepsy-type-1
• Healio. (2025). Gastrocrom: Uses, Side Effects & Dosage. Clinical Guidance. https://www.healio.com/clinical-guidance/gastroenterology/gastrocrom-uses-side-effects-dosage
• Henderson, F. C., Sr, Austin, C., Benzel, E., Bolognese, P., Ellenbogen, R., Francomano, C. A., … & Patel, S. (2017). Neurological and spinal manifestations of the Ehlers-Danlos syndromes. American Journal of Medical Genetics Part C, 175(1), 195–211. https://doi.org/10.1002/ajmg.c.31549
• Herbst, K. L., Kahn, L. A., Iker, E., Ehrlich, C., Wright, T., McHutchison, L., … & Donahue, P. M. (2021). Standard of care for lipedema in the United States. Phlebology, 36(10), 779–796. https://doi.org/10.1177/02683555211015887
• Hoogland, I. C., Houbolt, C., van Westerloo, D. J., van Gool, W. A., & van de Beek, D. (2015). Systemic inflammation to neuroinflammation: the role of macrophages and microglia. Frontiers in Cellular Neuroscience, 9, 281. https://doi.org/10.3389/fncel.2015.00281
• Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., … & Nedergaard, M. (2012). A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Science Translational Medicine, 4(147), 147ra111. https://doi.org/10.1126/scitranslmed.3003748
• Ingber, D. E. (2008). Tensegrity and mechanotransduction. Journal of Bodywork and Movement Therapies, 12(3), 198–200. https://doi.org/10.1016/j.jbmt.2008.04.038\
• Järvelä, M., Kananen, J., Korhonen, V., Huotari, N., Raatikainen, V., Tuunanen, P., … & Kiviniemi, V. (2025). Arousal State Control of Physiological Human Brain Pulsations. bioRxiv. https://doi.org/10.1101/2025.01.27.635032v1
• Jason, L. A., et al. (2015). Post-exertional malaise in ME/CFS. Journal of Health Psychology, 20(8), 1010–1019. https://doi.org/10.1177/1359105313500582
• Kalesnikoff, J., & Galli, S. J. (2008). New developments in mast cell biology. Nature Immunology, 9(11), 1215–1223. https://doi.org/10.1038/ni.f.216
• Kampoureli, C. N., Rae, C. L., Gould Van Praag, C., Harrison, N. A., Garfinkel, S. N., Critchley, H. D., & Eccles, J. A. (2025). Neural processes linking joint hypermobility and anxiety: key roles for the amygdala and insular cortex. BJPsych, 1–7. https://doi.org/10.1192/bjp-2024.259
• Kavi, T., et al. (2016). Cerebral hypoperfusion and cognitive dysfunction in postural orthostatic tachycardia syndrome. Autonomic Neuroscience, 198, 54–57. https://doi.org/10.1016/j.autneu.2015.12.001
• Kempuraj, D., Selvakumar, G. P., Thangavel, R., Ahmed, M. E., Zaheer, S., Raikwar, S. P., … & Zaheer, A. (2017). Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer’s Disease Pathogenesis. Frontiers in Cellular Neuroscience, 11, 403. https://doi.org/10.3389/fncel.2017.00403
• Kirby, A., & Davies, R. (2007). Developmental Coordination Disorder and Joint Hypermobility Syndrome: overlapping disorders? Developmental Medicine & Child Neurology, 49(5), 343–345. https://doi.org/10.1111/j.1469-8749.2007.00343.x
• Kolkhir, P., et al. (2019). Mechano-immunologic mechanisms of mast cell degranulation in dermatographia. Journal of Allergy and Clinical Immunology, 144(2), 481–489. https://doi.org/10.1016/j.jaci.2019.03.018
• Kolla, B. P., et al. (2013). Autonomic dysfunction in narcolepsy. Sleep Medicine, 14(11), 1083–1088. https://doi.org/10.1016/j.sleep.2013.06.006
• Kopec, A. M., Smith, C. J., Ayre, N. R., Sweat, S. C., & Bilbo, S. D. (2018). Microglial elimination of dopamine receptors defines sex-specific trajectories of adolescent development. Nature Communications, 9(1), 3769. https://doi.org/10.1038/s41467-018-06118-z
• Kovacheva, E., Gevezova, M., Maes, M., & Sarafian, V. (2024). Mast Cells in Autism Spectrum Disorder—The Enigma to Be Solved? International Journal of Molecular Sciences, 25(5), 2651. https://doi.org/10.3390/ijms25052651
• Kreider, R. B., Jäger, R., & Purpura, M. (2022). Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review. Nutrients, 14(5), 1035. https://doi.org/10.3390/nu14051035
• Kucuk, E. E., Oguz, K. K., Yilmaz, O., Ersu, E., Ekmekci, H., & Boyaci, Z. (2023). Assessment of glymphatic function in narcolepsy using DTI-ALPS index. Sleep Medicine, 103, 1-6. https://doi.org/10.1016/j.sleep.2023.01.011
• Latorre, D., Kallweit, U., Armentani, E., Foglierini, M., Mele, F., Cassotta, A., … & Sallusto, F. (2018). T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature, 562(7725), 63–68. https://doi.org/10.1038/s41586-018-0540-1
• Lensjø, K. K., Lepperød, M. E., Dick, G., Hafting, T., & Fyhn, M. (2017). Removal of Perineuronal Nets Unlocks Juvenile Plasticity Through Network Mechanisms of Decreased Inhibition and Increased Gamma Activity. Journal of Neuroscience, 37(5), 1269–1283. https://doi.org/10.1523/JNEUROSCI.2504-16.2016
• Lenz, K. M., & McCarthy, M. M. (2015). A starring role for microglia in brain sex differences. The Neuroscientist, 21(3), 306–321. https://doi.org/10.1177/1073858414536468
• Litman, A., Sauerwald, N., Foss-Feig, H. C., Theesfeld, C. L., & Troyanskaya, O. G. (2025). Decomposition of phenotypic heterogeneity in autism reveals underlying genetic programs. Nature Genetics. https://doi.org/10.1038/s41588-025-01800-0 
• Liu, Y., et al. (2025). The temporal relationship between pubertal onset and narcolepsy presentation. Sleep, 48(2), 114–122. https://pubmed.ncbi.nlm.nih.gov/?term=Liu+Y+The+temporal+relationship+between+pubertal+onset+and+narcolepsy+presentation
• Luo, G., Ambati, A., Lin, L., Bonvalet, M., Partinen, M., Ji, X., … & Mignot, E. (2018). Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proceedings of the National Academy of Sciences, 115(52), E12323-E12332. https://doi.org/10.1073/pnas.1818150116
• Macedo, D. S., et al. (2026). Regulatory cycles of orexin and glucagon-Like peptide-1 in postviral syndromes. Endocrine Reviews, bnag009. https://pubmed.ncbi.nlm.nih.gov/?term=Regulatory+cycles+of+orexin+and+glucagon-Like+peptide-1+in+postviral+syndromes
• Mahlios, J., De la Herrán-Arita, A. K., & Mignot, E. (2013). The autoimmune basis of narcolepsy. Current Opinion in Neurobiology, 23(5), 767–773. https://doi.org/10.1016/j.conb.2013.04.013
• Mahoney, C. E., Cogswell, A., Koralnik, I. J., & Scammell, T. E. (2019). The neurobiological basis of narcolepsy. Nature Reviews Neuroscience, 20(2), 83–93. https://doi.org/10.1038/s41583-018-0097-x
• Mahony, C., & O’Ryan, C. (2022). A molecular framework for autistic experiences: Mitochondrial allostatic load as a mediator between autism and psychopathology. Frontiers in Psychiatry, 13, 985713. https://doi.org/10.3389/fpsyt.2022.985713
• Maintz, L., & Novak, N. (2007). Histamine and histamine intolerance. The American Journal of Clinical Nutrition, 85(5), 1185–1196. https://doi.org/10.1093/ajcn/85.5.1185
• Malfait, F., et al. (2015). Brain morphology in Ehlers-Danlos syndrome. Orphanet Journal of Rare Diseases, 10, 56. https://doi.org/10.1186/s13023-015-0271-x
• Mantle, D., Hargreaves, I. P., Domingo, J. C., & Castro-Marrero, J. (2024). Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview. International Journal of Molecular Sciences, 25(1), 574. https://doi.org/10.3390/ijms25010574
• Maski, K., et al. (2021). Narcolepsy misdiagnosis in pediatric patients with ADHD. Pediatrics, 148(4), e202105156. https://doi.org/10.1542/peds.2021-05156
• Mazurek, M. O., & Petrosko, H. (2012). Sleep problems in children with autism spectrum disorder: examining the contributions of sensory over-responsivity and anxiety. Sleep Medicine, 13(3), 270–276. https://doi.org/10.1016/j.sleep.2011.08.005
• McMakin, C. (2010). Frequency Specific Microcurrent in Pain Management. Elsevier Health Sciences. https://pubmed.ncbi.nlm.nih.gov/?term=Frequency+Specific+Microcurrent+in+Pain+Management
• Medical News Today. (2024). Hypermobility and Exercise Avoidance. MNT Clinical Reviews. https://www.medicalnewstoday.com/articles/hypermobility-syndrome
• Medow, M. S., et al. (2014). Decreased cerebral blood flow directly correlates with diminished neurocognition in POTS. Circulation: Arrhythmia and Electrophysiology, 7(6), 1102–1109. https://doi.org/10.1161/CIRCEP.114.001602
• Melzi, V., et al. (2022). Narcolepsy and precocious puberty: a temporal and clinical link. Pediatric Neurology, 130, 45–51. https://doi.org/10.1016/j.pediatrneurol.2022.01.012
• Mottron, L., Dawson, M., Soulières, I., Hubert, B., & Burack, J. (2006). Enhanced perceptual functioning in autism: an update, and eight principles of autistic perception. Journal of Autism and Developmental Disorders, 36(1), 27–43. https://doi.org/10.1007/s10803-005-0040-7
• Musazzi, L., Sala, N., Tornese, P., Chen, F., Tardito, D., Mingardi, J., … & Popoli, M. (2019). Acute Inescapable Stress Rapidly Increases Synaptic Energy Metabolism in Prefrontal Cortex and Alters Working Memory Performance. Cerebral Cortex, 29(12), 4983–4994. https://doi.org/10.1093/cercor/bhz036
• Navarro, R., et al. (2014). Mast cells and mechanosensitivity: the role of shear forces and mechanical stress. Immunology, 141(4), 562–570. https://doi.org/10.1111/imm.12215
• Naviaux, R. K. (2014). Metabolic features of the cell danger response. Mitochondrion, 16, 7–17. https://doi.org/10.1016/j.mito.2013.08.006
• Naviaux, R. K., et al. (2016). Metabolic features of chronic fatigue syndrome. Proceedings of the National Academy of Sciences, 113(37), E5472-E5480. https://doi.org/10.1073/pnas.1607571113
• Nedergaard, M., & Goldman, S. A. (2020). Glymphatic failure as a final common pathway to dementia. Science, 370(6512), 50–56. https://doi.org/10.1126/science.abb8739
• Neher, M. D., Weckbach, S., Flierl, M. A., Huber-Lang, M. S., & Stahel, P. F. (2011). Molecular mechanisms of inflammation and tissue injury after major trauma-is complement the “bad guy”?. Journal of Biomedical Science, 18(1), 90. https://doi.org/10.1186/1423-0127-18-90
• Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2003). IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation, 113(9), 1271–1276. https://doi.org/10.1172/JCI17799
• Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., … & Ganz, T. (2004). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 306(5704), 2090–2093. https://doi.org/10.1126/science.1104742
• Obaydi, H., & Puri, B. K. (2008). Prevalence of premenstrual syndrome in autism: a prospective observer-rated study. Journal of International Medical Research, 36(2), 268–272. https://doi.org/10.1177/147323000803600210
• Obeid, R., Holzgreve, W., & Pietrzik, K. (2013). Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects? Journal of Perinatal Medicine, 41(5), 469–483. https://doi.org/10.1515/jpm-2012-0256
• Osredkar, J., & Sustar, N. (2011). Copper and Zinc, Biological Role and Significance of Copper/Zinc Imbalance. Journal of Clinical Toxicology, S3, 001. https://doi.org/10.4172/2161-0495.S3-001
• Park, S.-K., Stefanyshyn, D. J., Loitz-Ramage, B., Hart, D. A., & Ronsky, J. L. (2009). Changing Hormone Levels during the Menstrual Cycle Affect Knee Laxity and Stiffness in Healthy Female Subjects. The American Journal of Sports Medicine, 37(3), 588–598. https://doi.org/10.1177/0363546508326713
• Partridge, S., Quadt, L., Bolton, M., Eccles, J., Thompson, C., Colasanti, A., Bremner, S., Jones, C. I., Bruun, K. D., & Van Marwijk, H. (2023). A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia. Heliyon, 9, e15638. https://doi.org/10.1016/j.heliyon.2023.e15638
• Penzes, P., et al. (2022). Molecular Profiling of the Hippocampus of Children with Autism Spectrum Disorder. MedRxiv (Preprint). https://doi.org/10.1101/2022.10.13.22281011
• Petrucci-Nelson, A., et al. (2025). The ACKR3 locus and environmental regulation in hypermobility spectrum disorders. Genetics in Medicine, 27(1), 101–114. https://pubmed.ncbi.nlm.nih.gov/?term=Petrucci-Nelson+ACKR3+locus+and+environmental+regulation
• Plazzi, G., et al. (2006). Precocious puberty and childhood narcolepsy-cataplexy. Pediatrics, 118(3), 1145–1149. https://doi.org/10.1542/peds.2006-0761
• Quadt, L., Csecs, J., Bond, R., Harrison, N. A., Critchley, H. D., Davies, K. A., & Eccles, J. (2024). Childhood neurodivergent traits, inflammation and chronic disabling fatigue in adolescence: a longitudinal case-control study. BMJ Open, 14, e084203. https://doi.org/10.1136/bmjopen-2024-084203
• Rauch, S. L., van der Kolk, B. A., Fisler, R. E., Alpert, N. M., Orr, S. P., Savage, C. R., … & Pitman, R. K. (1996). A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Archives of General Psychiatry, 53(5), 380–387. https://doi.org/10.1001/archpsyc.1996.01830050014003
• Rolnick, N., et al. (2021). Blood flow restriction training and the hypermobile patient. Physical Therapy & Rehabilitation Journal, 101(12). https://doi.org/10.1093/ptj/pzab215
• Rossetti, Y., Rode, G., Pisella, L., Farné, A., Li, L., Boisson, D., & Perenin, M. T. (1998). Prism adaptation to a rightward optical deviation rehabilitates left hemispatial neglect. Nature, 395(6698), 166–169. https://doi.org/10.1038/25988
• Scammell, T. E. (2015). Narcolepsy. New England Journal of Medicine, 373(27), 2654–2662. https://doi.org/10.1056/NEJMra1500587
• Scammell, T. E., Jackson, A. C., Franks, N. P., Wisden, W., & Dauvilliers, Y. (2019). Histamine: neural circuits and new medications. Sleep, 42(1), zsy183. https://doi.org/10.1093/sleep/zsy183
• Schiappa, C., Scarpelli, S., D’Atri, A., Gorgoni, M., & De Gennaro, L. (2018). Narcolepsy and emotional experience: a review of the literature. Journal of Clinical Medicine, 7(12), 440. https://doi.org/10.3390/jcm7120440
• Schwartz, S., Ponz, A., Poryazova, R., Werth, E., Boesiger, P., Khatami, R., & Bassetti, C. L. (2008). Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. Brain, 131(2), 514–522. https://doi.org/10.1093/brain/awm292
• Seneviratne, S. L., et al. (2017). Mast cell activation in hypermobile Ehlers-Danlos syndrome. Clinical and Experimental Immunology, 188(3), 390–395. https://doi.org/10.1111/cei.12937
• Sheehan, D. S., Oliemans, J. P., Golden, D. W., Walls, K. D., Bennett, E. C., Skaper, S. J., Asmussen, M. J., Manocha, R. H. K., & Fletcher, J. R. (2026). To what extent do the muscles and tendons influence metabolic cost and exercise tolerance in the hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders?. Clinical Biomechanics, 131, 106695. https://doi.org/10.1016/j.clinbiomech.2025.106695
• Shirvani, P., Shirvani, A., & Holick, M. F. (2024). Decoding the Genetic Basis of Mast Cell Hypersensitivity and Infection Risk in Hypermobile Ehlers-Danlos Syndrome. Current Issues in Molecular Biology, 46(10), 11613–11629. https://doi.org/10.3390/cimb46100689
• Shirvani, P., Shirvani, A., & Holick, M. F. (2025). Mitochondrial Dysfunction and Its Potential Molecular Interplay in Hypermobile Ehlers-Danlos Syndrome: A Scoping Review Bridging Cellular Energetics and Genetic Pathways. Current Issues in Molecular Biology, 47, 134. https://doi.org/10.3390/cimb47020134
• Simmonds, J. V., & Keer, R. J. (2007). Hypermobility and the hypermobility syndrome. Manual Therapy, 12(4), 298–309. https://doi.org/10.1016/j.math.2007.03.003
• Smith, R., et al. (2013). Proprioception and end-range seeking in benign joint hypermobility syndrome. Journal of Biomechanics, 46(12), 1980–1985. https://doi.org/10.1016/j.jbiomech.2013.06.012
• Soangra, R., et al. (2021). Biomechanical compensations of toe-walking in pediatric hypermobility. Clinical Biomechanics, 83, 105307. https://doi.org/10.1016/j.clinbiomech.2021.105307
• Society for Women’s Health Research (SWHR). (2022). Rising to a Better Tomorrow: Addressing the Impact of Narcolepsy on Women’s Health. SWHR Roundtable Reports. https://swhr.org/rising-to-a-better-tomorrow-addressing-the-impact-of-narcolepsy-on-womens-health/
• Soppi, E. T. (2018). Iron deficiency without anemia – a clinical challenge. Clinical Case Reports, 6(6), 1082–1086. https://doi.org/10.1002/ccr3.1529
• StatPearls. (2024). Cromolyn Sodium. National Center for Biotechnology Information, U.S. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK557762/
• Sun, H., Hao, Y., Liu, H., & Gao, F. (2025). The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment. Frontiers in Immunology, 16, 1525623. https://doi.org/10.3389/fimmu.2025.1525623
• Surén, P., et al. (2012). Autism and ADHD comorbidities: an epidemiological analysis. Autism Research, 5(6), 397–405. https://doi.org/10.1002/aur.1256
• Syed, A. M., Karius, A. K., Ma, J., Wang, P.-y., & Hwang, P. M. (2025). Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Physiology, 40(4). https://doi.org/10.1152/physiol.00056.2024
• Szewczuk, V., et al. (2024). Mitochondrial bioenergetic failure in connective tissue disorders: A scoping review. Mitochondrion, 74, 114–125. https://doi.org/10.1016/j.mito.2023.11.002
• Talkington, J., & Nickell, S. P. (1999). Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release. Infection and Immunity, 67(3), 1107–1115. https://doi.org/10.1128/IAI.67.3.1107-1115.1999
• Tamilson, B., Eccles, J. A., & Shaw, S. C. K. (2025). The experiences of autistic adults who were previously diagnosed with borderline or emotionally unstable personality disorder: A phenomenological study. Autism, 29(2), 504–517. https://doi.org/10.1177/13623613241276073
• Teitelbaum, J. E., et al. (2006). The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. Journal of Alternative and Complementary Medicine, 12(9), 857–862. https://doi.org/10.1089/acm.2006.12.857
• Theoharides, T. C., et al. (2019). Substance P and CGRP regulate mast cell activation via MRGPRX2. Journal of Neuroimmunology, 332, 23–29. https://doi.org/10.1016/j.jneuroim.2019.03.013
• Theoharides, T. C., et al. (2021). Long COVID and mast cell activation syndrome. International Journal of Immunopathology and Pharmacology, 35. https://doi.org/10.1177/20587384211000141
• Thomas, M., et al. (2000). Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. Journal of Sleep Research, 9(4), 335–352. https://doi.org/10.1046/j.1365-2869.2000.00223.x
• Thomson, C. A., et al. (2017). DIM (Diindolylmethane) and its effects on estrogen metabolism. Cancer Epidemiology, Biomarkers & Prevention, 26(8), 1279–1287. https://doi.org/10.1158/1055-9965.EPI-17-0205
• Torok, R. A., Lubell, J., Rudy, R. M., Eccles, J. A., & Quadt, L. (2025). Variant connective tissue as a risk factor for Long COVID: a case-control study. medRxiv. https://doi.org/10.1101/2025.02.27.25323047
• Tsilioni, I., & Theoharides, T. C. (2024). Flavonoids as targeted mast cell stabilizers and MMP-9 inhibitors. Pharmacology & Therapeutics, 255, 108602. https://doi.org/10.1016/j.pharmthera.2024.108602
• Tucker, D., et al. (2018). Methylene blue for mitochondrial dysfunction. Progress in Neurobiology, 162, 27–45. https://doi.org/10.1016/j.pneurobio.2017.11.003
• Valdez, A. R., et al. (2019). Epidemiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A review of women vs men. Fatigue: Biomedicine, Health & Behavior, 7(1), 16–34. https://doi.org/10.1080/21641846.2019.1581283
• Valiani, V., et al. (2024). The role of the creatine kinase–phosphocreatine system in mitigating mitochondrial bioenergetic failure. Clinical Therapeutics, 46(2), 210–225. https://doi.org/10.1016/j.clinthera.2024.01.005
• Vassalli, A., Li, S., & Franken, P. (2022). Effects of sex and estrous cycle on sleep and cataplexy in narcoleptic mice. Sleep, 45(7), zsac089. https://doi.org/10.1093/sleep/zsac089
• Vienne, J., Bettler, B., Franken, P., & Tafti, M. (2012). Differential Effects of Sodium Oxybate and Baclofen on EEG, Sleep, Neurobehavioral Performance, and Memory. Sleep, 35(8), 1071–1083. https://doi.org/10.5665/sleep.1990
• Villa, A., Vegeto, E., Poletti, A., & Maggi, A. (2016). Estrogens, Neuroinflammation, and Neurodegeneration. Endocrine Reviews, 37(4), 272–311. https://doi.org/10.1210/er.2015-1082
• Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2018). The Perineuronal “Safety” Net? Perineuronal Net Abnormalities in Neurological Disorders. Frontiers in Molecular Neuroscience, 11, 270. https://doi.org/10.3389/fnmol.2018.00270
• Wirth, K. J., & Scheibenbogen, C. (2021). Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Journal of Translational Medicine, 19, Article 162. https://doi.org/10.1186/s12967-021-02833-2. 
• Won, C., Mahmoudi, M., Qin, L., Purvis, T., Mathur, A., & Mohsenin, V. (2014). The impact of gender on timeliness of narcolepsy diagnosis. Journal of Clinical Sleep Medicine, 10(1), 89–95. https://doi.org/10.5664/jcsm.3368
• Yang, L., et al. (2023). Craniocervical instability and internal jugular vein compression: clinical implications. Spine Journal, 23(1), 58–67. https://doi.org/10.1016/j.spinee.2022.09.006
• Zhang, D., et al. (2008). Mechanical stress triggers mast cell degranulation via ion channel activation. Cellular Immunology, 251(2), 123–131. https://doi.org/10.1016/j.cellimm.2007.12.001
• Zhao, S., Zhang, M., Luo, T., Li, L., Jiang, Y., Situ, M., & Huang, Y. (2025). Glymphatic system dysfunction in children with autism spectrum disorder as evidenced by the diffusion tensor imaging along perivascular spaces index. Frontiers in Psychiatry, 16, 1701816. https://doi.org/10.3389/fpsyt.2025.1701816
• Zhang, X., Grove, J., Gu, Y., Buus, C. K., Nielsen, L. K., Neufeld, S. A. S., Kokos, M., Malawsky, D. S., Wade, E. M., Verhoef, E., Gui, A., Hegemann, L., APEX Consortium, iPSYCH Autism Consortium, PGC-PTSD Consortium, Geschwind, D. H., Wray, N. R., Havdahl, A., Ronald, A., St Pourcain, B., Robinson, E. B., Bourgeron, T., Baron-Cohen, S., Børglum, A. D., Martin, H. C., & Warrier, V. (2025). Polygenic and developmental profiles of autism differ by age at diagnosis. Nature, 646, 1146-1155. https://doi.org/10.1038/s41588-025-01800-0
• Zheng, T., et al. (2023). Avoidant/Restrictive Food Intake Disorder and its connection to hypermobility and gastrointestinal dysmotility. Journal of Pediatric Gastroenterology and Nutrition, 76(4), 450–456. https://doi.org/10.1097/MPG.0000000000003714
• Zhu, Y., et al. (2024). Estrogen establishes a self-reinforcing inflammatory loop via mast cell degranulation. Journal of Endocrinology, 261(1), 89–102. https://doi.org/10.1530/JOE-23-0182